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Summary 
Cell-cell junctions respond to mechanical forces by changing their organization and function. The 
molecular processes underlying this mechanosensitivity are still incompletely understood.  Here we 
show that in the gastrulating zebrafish embryo, tight junction (TJ) mechanosensitivity is mediated by 
actomyosin-driven flow of phase-separated Zonula Occludens-1 (ZO-1) clusters. We found that ZO-1 
junctional accumulation at the contact between the Enveloping Layer (EVL) and the Yolk Syncytial 
Layer (YSL) closely scales with actomyosin tension. Actomyosin tension triggers ZO-1 junctional 
accumulation by driving retrograde actomyosin flow within the YSL that transport non-junctional ZO-
1 clusters towards the TJ. Non-junctional ZO-1 clusters form by phase separation, and direct binding 
of ZO-1 to actin is required for stable incorporation of ZO-1 clusters into TJ. If the formation and/or 
junctional incorporation of ZO-1 clusters is impaired, TJ lose their mechanosensitivity, and, 
consequently, EVL-YSL movement is delayed. Thus, phase separation and flow of non-junctional ZO-1 
confer mechanosensitivity to TJ. 
 
Introduction 
A key step in the emergence of multicellularity is the development of different junctional complexes 
mechanically connecting cells and allowing the transfer of biochemical and mechanical signals 
between cells. The molecular composition and dynamic regulation of different cell-cell junction 
types, such as adherens junctions (AJ), tight junctions (TJ) and desmosomes, have been extensively 
studied over the past decades (Van Itallie and Anderson 2014; Franke 2009; Godsel et al. 2004; 
Niessen 2007). Likewise, detailed insight has been gained in the intracellular signaling cascades 
activated by the different junctional complexes and their function in tissue homeostasis (Matter and 
Balda 2003; Wheelock and Johnson 2003; Johnson, Najor, and Green 2014; Zihni et al. 2016). There 
is also compelling evidence that changes in the molecular composition, size and turnover of 
junctional complexes directly affect both their mechanical integrity and signaling activity (Baum and 
Georgiou 2011; Shen, Weber, and Turner 2008; Cunningham and Turner 2012; Nekrasova and Green 
2013). In contrast, much less is known about how mechanical forces influence cell-cell junction 
formation and signaling. 
 
Recent studies on AJ indicate that mechanical forces and actin dynamics at E-cadherin-mediated cell-
cell contacts can promote E-cadherin clustering, leading to the formation of larger and more stable 
junctional complexes (Engl et al. 2014; Ladoux et al. 2010; M. Cavey and Lecuit 2009; Matthieu 
Cavey et al. 2008). An important step in this mechanosensing process is the modulation of AJ 
anchoring to the cortical actomyosin network, with junctional tension changing the conformation of 
AJ components, such as α-catenin and vinculin, thereby increasing their binding capacity to the 
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actomyosin network (Gomez, McLachlan, and Yap 2011; Watabe-Uchida et al. 1998; Weiss et al. 
1998; Yonemura et al. 2010). Tension-dependent changes in the composition and organization of AJ 
are thought to affect both their coupling strength and signaling activity (Gomez, McLachlan, and Yap 
2011). While recent studies suggest that certain components of other junction types, such as TJ, can 
in principle undergo conformational changes upon mechanical loading (Spadaro et al. 2017), it is not 
yet entirely clear whether and how this molecular mechanosensitivity translates into changes of 
global junction organization and function. 
 
TJ play an essential role in tissue homeostasis by limiting the passage of molecules and ions between 
cells and restricting the movement of molecules between the apical and basolateral domains 
thereby maintaining apicobasal polarity of epithelial cells (Shin, Fogg, and Margolis 2006). Similar to 
AJ, TJ are composed of transmembrane proteins, such as Occludins and Claudins, and cytoplasmic 
scaffolding proteins connecting the transmembrane proteins to the cytoskeleton, e.g. Zonula 
Occludens (ZO) proteins and Cingulins (Zihni et al. 2016). TJ also function as intracellular signaling 
centers regulating the activity of small Rho GTPases, such as RhoA and Cdc42, thereby affecting 
actomyosin network organization and contraction at the junction (Zihni and Terry, 2015). 
Conversely, actomyosin regulators such as RhoA, Cdc42 and Rac have been shown to be important 
for TJ formation (Zihni et al., 2016); yet, to what extent mechanical signals, for instance by triggering 
conformational changes of TJ components (Spadaro et al., 2017), are involved in this process still 
needs to be demonstrated. 
 
During zebrafish epiboly, the enveloping cell layer (EVL), a simple squamous epithelial monolayer 
covering the blastoderm at the animal pole of the yolk cell, spreads together with the underlying 
deep cells over the entire yolk cell (Figure 1A) (Lepage and Bruce 2010; Bruce 2016). EVL spreading is 
driven by a large actomyosin ring-like structure positioned within the yolk syncytial layer (YSL) on the 
surface of the yolk cell and presumably coupled to the EVL leading edge by TJ (Figure 1A) (Behrndt et 
al. 2012; Holloway et al. 2009; Köppen et al. 2006; Cheng, Miller, and Webb 2004). The actomyosin 
ring drives EVL spreading by actively pulling on the EVL-leading edge through two distinct motor-
activities: (i) a cable-constriction motor, where the actomyosin band constricts around its 
circumference, thereby generating pulling forces on the EVL margin once the band has crossed the 
yolk cell equator; and (ii) a flow-friction motor, where a gradient of actomyosin tension along the 
width of the actomyosin band gives rise to retrograde actomyosin flow (Behrndt et al. 2012). This 
actomyosin flow, when resisted by friction to adjacent structures within the YSL, will generate a 
traction force pulling the EVL margin towards the vegetal pole (Behrndt et al. 2012). The pulling 
forces generated by the actomyosin band within the YSL are likely transmitted to the margin of the 
EVL by junctional complexes connecting the leading edge of the EVL to the YSL (Behrndt et al. 2012; 
Köppen et al. 2006). Whether and how junction formation at the EVL-YSL boundary relates to 
actomyosin ring formation and function within the YSL is still unknown. 
 
Here, we show that TJ rather than AJ components accumulate at the EVL-YSL boundary during the 
course of EVL epiboly, and that this accumulation closely scales with the degree of actomyosin 
tension within the YSL. We further show that the accumulation of TJ components at the EVL-YSL 
boundary is mediated by tension-dependent retrograde actomyosin flow within the YSL transporting 
non-junctional phase-separated ZO-1b clusters towards the boundary. Finally, we show that the 
junctional incorporation of those clusters depends on ZO-1b binding to actin, and that the 
mechanosensitive response of TJ at the EVL-YSL junction is required for proper EVL spreading. 
 
Results 
Tight junction components accumulate at the EVL-YSL boundary 
We have previously noted that both AJ and TJ components localize to the boundaries between EVL 
cells and at the leading edge of the EVL where it contacts the YSL (Köppen et al. 2006). To investigate 
which junctions form at the EVL-YSL boundary during the course of EVL epiboly, we systematically 
analyzed how the localization of various AJ and TJ components changes. Interestingly, we found that 
the accumulation of components typically associated with AJ, such as E-cadherin, α-catenin and β-
catenin, decreased at the EVL-YSL boundary during epiboly (Figures 1A-D and S1A-D). In contrast, the 
accumulation of various components typically associated with TJ either increased (ZO-1b, Cingulin-
like 1) or remained unchanged (ZO-3, Claudin-D and Occludin-A) at this boundary during epiboly 
(Figures 1A-D and S1A-D). This suggests that during the course of EVL epiboly, TJ becomes the 
predominant junction type connecting the EVL leading edge to the YSL. 
 
ZO-1b and ZO-3 are required for proper EVL epiboly movements by regulating actomyosin flow and 
tension within the YSL 
To determine whether this accumulation of TJ components at the EVL-YSL boundary during epiboly is 
functionally relevant for EVL epiboly movements, we sought to interfere with the expression of 
those components and analyze resultant changes in EVL epiboly movements. Given the known 
signaling function of TJ in regulating actin network organization and contraction (Zihni and Terry 
2015), we speculated that TJ might function in EVL epiboly movements by controlling actomyosin 
ring formation and flow within the YSL, previously shown to drive EVL epiboly movements (Behrndt 
et al. 2012). To test this possibility, we injected morpholinos (MO) directed against the TJ 
components zo-1b and zo-3, previously implicated in TJ organization and signaling to the actomyosin 
cytoskeleton (Itoh et al. 2012; Otani et al. 2006; Tornavaca et al. 2015; Wittchen, Haskins, and 
Stevenson 2003), directly into the YSL to specifically interfere with ZO-1b/3 expression at the EVL-
YSL boundary (Figure 2A). YSL morphant embryos displayed clearly reduced EVL epiboly movements, 
which could be partially rescued by co-injecting GFP-tagged zo-1b and zo-3 mRNA (Figure 2A-A’’, 
Video S1). In contrast, injection of zo-1b and zo-3 mismatch MOs or a standard negative control MO 
into the YSL did not elicit a recognizable epiboly phenotype (Figure S2A), supporting the specificity of 
the zo-1b/3 MO effect. Slower EVL spreading was accompanied by diminished retrograde 
actomyosin flow and ring formation within the YSL (Figure 2C-C’,D-D’, Video S2), a phenotype that 
could be partially rescued by co-injecting GFP-tagged zo-1b and zo-3 mRNA  (Figures 2C-C’,D-D’, 
Video S2). Notably, the epiboly phenotype in zo-1b/3 morphant embryos was not due to a general 
developmental delay, as YSL morphant embryos formed the first somite, visualized by papc 
expression, at the same time as their control injected siblings (Figure S2B-B’). Together, these 
observations suggest that TJ formation at the EVL-YSL boundary is required for EVL epiboly 
movements by regulating actomyosin flow and ring formation within the YSL.  
 
To determine whether the obtained morphant phenotypes were specific, we generated maternal-
zygotic (MZ) mutants for the TJ components ZO-1b and ZO-3, using CRISPR/Cas9 technique (Figure 
S2C). We found that in MZzo-1b and MZzo-3 single mutants, EVL spreading appeared largely 
unaffected (Figure S2D). Interestingly, MZzo-1b/3 double mutants displayed a phenotype closely 
resembling the phenotypes observed in embryos where ZO-1b and ZO-3 expression was knocked 
down either uniformly or locally within the YSL using MOs (Figures 2B-B’’, A-A’’ and S2G’’). The 
phenotypic similarities between mutant and morphant embryos further suggest that the obtained 
zo-1b/3 morphant phenotypes were specific and, thus, that the zo-1b and zo-3 MOs can be used to 
analyze the function of those proteins in EVL-YSL epiboly. Additionally, when zo-1b/3 was 
ubiquitously knocked down or knocked out (MZzo-1b/3 mutants), the majority of morphant or 
mutant embryos formed the first somite on time (Figure S2E-E’), suggesting that the observed 
epiboly phenotype is not due to a general delay in the development of mutant or morphant 
embryos. Notably, TJ were reduced but not completely absent at the EVL-YSL boundary in zo-1b/3 
YSL morphants (Figure S2F-F’) and mutants (Figure S2G-G’), likely due to incomplete knockdown in 
morphant embryos and functional redundancy and/or compensatory upregulation in the expression 
of the remaining zo genes (zo-1a, zo-2a, zo-2b) in mutant embryos (Figure S2H).   
 
It has previously been shown that gradients of actomyosin contractility can trigger actin flows 
(Mayer et al. 2010; Munro, Nance, and Priess 2004; Lecuit, Lenne, and Munro 2011). Hence, we 
asked whether TJ components control actomyosin flow within the YSL by modulating tension at the 
EVL-YSL boundary. To address this possibility, we measured tension at the EVL-YSL boundary 
oriented along the circumference of the yolk cell in wild type and zo-1b/3 YSL morphant embryos 
using UV-laser ablation. We found that junctional tension was strongly reduced in zo-1b/3 YSL 
morphants compared to wild type embryos at late stages of epiboly (8 hpf; Figures 2E-E’’ and S2I-I’). 
Together, these data indicate that normal TJ formation is required for proper buildup of tension at 
the EVL-YSL boundary and, consequently, actomyosin flow within the YSL, which is required for 
proper EVL epiboly movements. 
 
Actomyosin contractility controls ZO-1 recruitment to the EVL-YSL boundary 
Our junctional tension measurements at the EVL-YSL boundary in wild type embryos also revealed 
that tension was considerably higher at late (8 hpf) compared to early-mid (6 hpf) stages of epiboly 
(Figures 2F-F’’ and S2J-J’), consistent with our previous observation that actomyosin network tension 
within the YSL increases during the course of epiboly (Behrndt et al. 2012). Interestingly, this 
increase of junctional tension coincides with TJ component accumulation at the EVL-YSL boundary 
(Figure 1A-D), pointing at the intriguing possibility that TJ might be mechanosensitive. To determine 
whether and how increased junctional tension at the EVL-YSL boundary relates to TJ formation at 
this interface, we sought to modulate actomyosin contractility within the YSL and determine 
resultant effects on TJ formation at the EVL-YSL boundary. To modulate actomyosin contractility 
specifically within the YSL, we performed YSL-injections of mRNAs encoding constitutive active (ca) 
versions of either Myosin Phosphatase (caMypt) (Smutny et al. 2017; Jayashankar et al. 2013) or 
RhoA (caRhoA) (Takesono et al. 2012), previously shown to decrease or increase actomyosin 
contractility, respectively. Strikingly, we found that in embryos with reduced actomyosin contractility 
and retrograde flow rates within the YSL (Figures S3A-A’,B-B’ and 2C-C’,D-D’ - ctrl), the accumulation 
of ZO-1b, at the EVL-YSL boundary was clearly reduced (Figure 3A-A’’). Conversely, ZO-1b at the EVL-
YSL boundary showed a premature and strong accumulation in embryos with increased actomyosin 
contractility and retrograde flow rates within the YSL (Figures 3B-B’’ and S3C-C’,D-D’). AJ 
components, in contrast, did not display any recognizable changes in response to altered actomyosin 
tension at the EVL-YSL junction (Figure S3E-E’). Collectively, these findings indicate that actomyosin 
network contractility and retrograde flow within the YSL triggers TJ component accumulation at the 
EVL-YSL boundary, suggesting that TJ at this boundary are mechanosensitive.  
 
Non-junctional clusters of ZO-1b within the YSL form by phase separation, undergo retrograde flows 
and are incorporated into TJ at the EVL-YSL boundary 
To understand how actomyosin network tension translates into the accumulation of TJ components 
at the EVL-YSL boundary, we performed high-resolution time-lapse imaging of ZO-1b accumulation 
at the EVL-YSL boundary at 7 hpf. Remarkably, in addition to junctional ZO-1b, we detected non-
junctional clusters of ZO-1b within the YSL close to the EVL-YSL boundary, which traversed at a 
similar velocity as the actomyosin network towards this boundary (Figure 4A-A’’,B-B’’, Video S3). ZO-
1b clusters arriving at the EVL-YSL boundary were then incorporated into the junction, thereby 
locally increasing the amount of ZO-1b at the junction (Figure 4C-C’). Closer analysis of these non-
junctional ZO-1b clusters showed that ZO-1b close to the EVL-YSL boundary displayed a tendency to 
fuse into larger clusters (Figure 4D-D’’, Video S4). Given that fusion of protein clusters or ‘droplets’ 
has previously been associated with protein phase separation (Brangwynne et al. 2009; P. Li et al. 
2012), this points at the intriguing possibility that non-junctional ZO-1b clusters within the YSL might 
form by phase separation. To form phase-separated droplets, multivalent interactions on an intra- or 
inter-molecular level are necessary (P. Li et al. 2012; Kato et al. 2012; Banani et al. 2017). Indeed, ZO-
1 can undergo multivalent interactions with other ZO proteins such as ZO-2 and ZO-3 as well as other 
TJ scaffolding proteins, such as Cingulins (Utepbergenov, Fanning, and Anderson 2006; A. S. Fanning 
et al. 1998). There is also evidence for intra-molecular interaction sites for ZO-1 and other members 
of the MAGUK (membrane-associated guanylate kinases) protein family (Ye, Zeng, and Zhang 2018; 
Lye et al. 2010; Spadaro et al. 2017; Alan S. Fanning et al. 2007). This suggests that ZO-1b might be 
capable of undergoing phase separation, and that this property might contribute to its previously 
demonstrated scaffolding function in recruiting other proteins to TJ (Bauer et al. 2010; Matter and 
Balda 2003; Alan S. Fanning and Anderson 2009).  
 
To test whether ZO-1b within the YSL shows further properties indicative of a phase separation 
process, we sought to analyze ZO-1b turnover in clusters adjacent to the EVL margin using 
Fluorescence recovery after photobleaching (FRAP). Based on previous observations that proteins 
undergoing liquid-liquid phase separation stay highly dynamic within phase-separated droplets 
(Brangwynne et al. 2009; Hyman, Weber, and Jülicher 2014), we hypothesized that if ZO-1b would 
undergo phase separation within the YSL, then the turnover of the ZO-1b non-junctional pool should 
be rather fast. Consistent with ZO-1b potentially undergoing phase separation, we found that at 
early-mid gastrulation stages (5-6 hpf) non-junctional ZO-1b showed fast turnover on a second scale 
(t1/2 fast = 4 sec) and almost all of it was mobile (99% mobile fraction) (Figure 4E-E’’). Interestingly, 
non-junctional ZO-1b also exhibited turnover on a minute scale (t1/2 slow = 140 sec) indicative of the 
presence of a second, slower ZO-1b species (Figure 4E-E’’). Surprisingly, however, at later 
gastrulation stages (7-8 hpf), the turnover time of non-junctional ZO-1b during the fast phase (t1/2 
fast) increased (4 sec to 13 sec) and its mobile fraction decreased (from 99% to 64% mobile fraction) 
(Figure 4F-F’’). This suggests that clusters of non-junctional ZO-1b within the YSL, initially displaying 
properties of liquid-liquid phase-separated condensates, might undergo a maturation process 
leading to their immobilization. Interestingly, analyzing turnover of ZO-1b directly at the EVL-YSL 
junction at early (5 hpf) and later stages of gastrulation (8 hpf) revealed an even smaller fraction 
(~40%) of mobile ZO-1b at both of these stages (Figure S4A-A’’,B-B’’), suggesting that junctional 
incorporation of ZO-1b might further promote its immobilization.  
 
To further test whether non-junction ZO-1b clusters indeed form by phase separation, we analyzed 
its dependency on concentration, a typical feature of a thermodynamically driven phase separation 
processes. To determine how the concentration of ZO-1b expressed within the YSL relates to cluster 
formation of ZO-1b, we analyzed the size and fusion rate of those clusters as a function of ZO-1b 
concentration within the YSL. We found that both the size and fusion rate of non-junctional clusters 
of ZO-1b linearly scaled with the concentration of ZO-1b expressed within the YSL (Figures 5A-A’’’ 
and S5A), demonstrating that cluster formation is dependent on ZO-1b concentration as expected 
for a phase separation mechanism.  
 
Different domains of ZO-1b have previously been associated with ZO proteins binding to each other 
(Utepbergenov, Fanning, and Anderson 2006; A. S. Fanning et al. 1998; Alan S. Fanning et al. 2007) 
and the actin cytoskeleton (Alan S. Fanning, Ma, and Anderson 2002; A. S. Fanning et al. 1998). To 
determine whether those multivalent interactions are important for ZO-1b cluster formation and 
presumed phase separation behavior, we generated deletion constructs lacking certain regions of 
ZO-1b and asked how this affects ZO-1b cluster formation. First, we tested a C-terminally truncated 
version of ZO-1b (ZO-1bΔC) (Figure 5B), which has recently been found in in vitro reconstitution and 
cell culture assays to be defective in undergoing phase separation likely due to changes in intra-
molecular interactions of the truncated protein (Beutel et al., n.d.). Substituting full-length ZO-1b 
with ZO-1bΔC by expressing ZO-1bΔC in Mzzo-1b/3 mutant embryos revealed that ZO-1bΔC 
exclusively localized to TJ between EVL cells and at the EVL-YSL boundary and was unable to form 
non-junctional clusters within the YSL (Figure 5C). This is consistent with the notion that non-
junctional ZO-1b clusters within the YSL might form by phase separation. 
 
Since the C-terminus of ZO-1b also harbors an actin binding region (ABR) (Alan S. Fanning, Ma, and 
Anderson 2002) (Figure 5B) and non-junctional ZO-1b appears to partially co-localize with the 
cortical actomyosin network within the YSL (Figure S5B-B’), we further hypothesized that the failure 
of ZO-1bΔC in undergoing phase separation and forming non-junctional clusters within the YSL might 
also be caused by its inability to directly bind to actin. To test this possibility, we generated a version 
of ZO-1b specifically lacking its ABR (ZO-1bΔABR) and substituted full-length ZO-1b with ZO-1bΔABR 
in MZzo-1b/3 mutant embryos. Unexpectedly, we found that in ZO-1bΔABR expressing MZzo-1b/3 
mutant embryos, non-junctional clusters still formed and underwent fusion similar to full-length ZO-
1b (Figure 5D-D’’). However, analysis of cluster size and shape in ZO-1bΔABR expressing embryos 
revealed that these clusters took more spherical droplet-like shapes compared to the elongated rod-
like shapes typically observed when expressing full-length ZO-1b (Figure 5D’’’-D’’’’). This points at the 
intriguing possibility that direct binding of ZO-1b to actin is not required for ZO-1b to undergo phase 
separation and to form non-junctional clusters within the YSL. Rather, actin binding might restrict 
the ability of ZO-1b to form more spherical droplet-like clusters within the YSL.  
 
To determine whether an intact actomyosin network is required for ZO-1b phase separation and 
cluster formation, we disassembled the actomyosin network within the YSL by exposing embryos to 
Latrunculin B blocking actin polymerization. Strikingly, disassembly of the actomyosin network led to 
the formation of much larger and more spherical droplet-like clusters of non-junctional ZO-1b within 
the YSL than found in DMSO-exposed control embryos (Figure 5E-E’’). Moreover, these clusters 
underwent fusion within the YSL despite the notable absence of actomyosin network structures 
between those clusters (Figures 5F and S5C-C’, Video S5), suggesting that these clusters can fuse 
independently from actomyosin network contraction. Collectively, these findings indicate that ZO-1b 
forms non-junctional clusters within the YSL by phase separation, and that ZO-1b binding to actin 
gives ZO-1b clusters within the YSL their characteristic elongated rod-like shapes.  
 
TJ mechanosensitivity is mediated by retrograde actomyosin flows within the YSL transporting non-
junctional phase-separated ZO-1b clusters towards the junction 
Next, we investigated whether ZO-1b phase separation is required for TJ mechanosensitivity at the 
EVL-YSL boundary. To this end we substituted full-length ZO-1b with ZO-1bΔC, incapable of forming 
phase-separated non-junctional clusters within the YSL (Figure 5C), by expressing ZO-1bΔC in MZzo-
1b/3 mutant embryos. For monitoring TJ mechanosensitivity, we increased YSL actomyosin tension 
by expressing caRhoA within the YSL and analyzed how this affects junctional accumulation of ZO-
1bΔC. We found that junctional ZO-1bΔC levels remained unchanged in response to caRhoA-
mediated increased actomyosin tension and flow within the YSL (Figure 6B-B’, A-A’ - ctrl), suggesting 
that the ability of ZO-1b to form non-junctional phase-separated clusters within the YSL is critical for 
TJ mechanosensitivity. Importantly, the failure of ZO-1bΔC to respond to increased actomyosin 
tension within the YSL is unlikely to be due to ZO-1bΔC being degraded or non-functional, as the 
total expression level of these two ZO-1 versions were comparable (Figure S6A-A’). 
 
To further determine whether ZO-1b directly binding to actin is needed for TJ mechanosensitivity, 
we substituted full-length ZO-1b with ZO-1bΔABR, lacking its actin binding region within the C-
terminus, by expressing ZO-1bΔABR in MZzo-1b/3 mutant embryos. Interestingly, we found that 
non-junctional ZO-1bΔABR clusters displayed retrograde flow within the YSL similar to clusters 
formed by full-length ZO-1b (Figure S5D-D’’), suggesting that direct binding of ZO-1b to actin is not 
required for it to undergo actomyosin-contraction dependent retrograde flow within the YSL. 
However, accumulation of non-junctional ZO-1bΔABR clusters close to the EVL-YSL boundary (Figure 
S5E-E’) and stable incorporation of ZO-1bΔABR clusters into TJ at this boundary were severely 
reduced with retrogradely flowing ZO-1bΔABR clusters - instead of being incorporated into TJ once 
arriving at the EVL-YSL boundary (Figure S6B-B’, Video S6) - frequently ‘bypassing’ this boundary or 
detaching from the junctional pool (Figure S6C-C’’). Analysis of the subcellular distribution of ZO-
1bΔABR clusters within the YSL further revealed that these clusters were not confined to the surface 
of the YSL, where the actomyosin cortex is located and most of the full-length ZO-1b clusters were 
found (Figure S6C-C’’), but more broadly distributed throughout the YSL (Figure S6C’’). This led to 
some of the ZO-1bΔABR clusters flowing below the TJ complex at the EVL-YSL boundary thereby 
bypassing this boundary and not being stably incorporated into the TJ (Figure S6C-C’’). To test 
whether this reduced junctional incorporation of ZO-1bΔABR interferes with TJ mechanosensitivity, 
we increased YSL actomyosin tension by expressing caRhoA and analyzed how this affects junctional 
accumulation of ZO-1bΔABR. Interestingly, we found that the increase in junctional levels of ZO-
1bΔABR in response to increased actomyosin tension and flow within the YSL was much less 
pronounced than observed for full-length ZO-1b (Figure 6C-C’). This suggests that direct binding of 
ZO-1b to the actomyosin cortex confines non-junctional ZO-1b clusters to the YSL surface, where 
they can be most effectively incorporated into the TJ at the EVL-YSL interface. 
 
Importantly, while substituting full-length ZO-1b with forms that can either not form phase-
separated clusters (ZO-1bΔC) or cannot directly bind actin (ZO-1bΔABR) abolished the effect of 
increased actomyosin tension on junctional accumulation of ZO-1b, both forms of ZO-1b still showed 
a substantial base-level junctional accumulation at the EVL-YSL boundary. This suggests that the 
formation, retrograde flow and junctional incorporation of ZO-1b clusters are needed to tune the 
amount of  junctional ZO-1b at EVL-YSL boundary with the tension of the associated YSL actomyosin 
cytoskeleton, but not for the general accumulation of junctional ZO-1b at this boundary. 
 
TJ mechanosensitivity is required for EVL spreading 
Finally, we tested whether TJ mechanosensitivity is required for normal EVL epiboly movements. To 
this end, we attempted to rescue the epiboly phenotype of zo-1b/3 YSL morphant embryos by 
injecting mRNA for either the full-length and thus mechanosensitive ZO-1b or the mechano-
insensitive ZO-1bΔC and ZO-1bΔABR versions. Strikingly, we found that while the full-length version 
of ZO-1b in combination with ZO-3 could partially rescue the delay in epiboly progression and 
actomyosin ring formation in the morphant (Figures 6D-D’,E-E’ and 2C-C’), expression of ZO-1bΔC or 
ZO-1bΔABR together with ZO-3 at the same stoichiometric ratios as their full-length counterpart 
failed to rescue these phenotypes (Figure 6D-D’,E-E’ and S6D-D’). This suggests that the C-terminus 
and, specifically, the ABR therein, is important for ZO-1b function in EVL-YSL epiboly movement, and 
- given that these parts of ZO-1b are also required for ZO-1b mechanosensitivity - that ZO-1b 
mechanosensitivity is important for EVL-YSL epiboly progression. 
 
Discussion 
Our study provides direct evidence that TJ mechanosensitivity is achieved by contractility-driven 
cortical actomyosin flow transporting phase-separated non-junctional ZO-1b clusters towards the 
junction. Recent biochemical evidence from in vitro reconstitution and cell culture experiments 
suggest that ZO proteins, like other members of the MAGUK family (Zeng et al. 2016), can undergo 
phase separation (Beutel et al., n.d.). Our data support these observations by showing that ZO-1b 
can undergo phase separation within the YSL. Importantly, the ability of ZO-1b to undergo phase 
separation seems to be required to form non-junctional clusters within the YSL, given that versions 
of ZO-1b incapable of undergoing phase separation, such as ZO-1bΔC (Beutel et al., n.d.), failed to 
form those clusters. Whether other TJ proteins also undergo phase separation and/or localize to ZO-
1b non-junctional clusters is not yet entirely clear. Our data so far suggest that TJ adhesion 
receptors, such as Occludins and Claudins, are exclusively localizing to TJ but do not form non-
junctional clusters (Figures S6E-F and S1A-D). In contrast, the cytoskeletal adapter protein Cingulin-
like 1/Paracingulin, previously shown to also localize to TJ  (Citi, Pulimeno, and Paschoud 2012; 
Guillemot et al. 2014), colocalizes with both junctional and non-junctional ZO-1b (Figure S6G-G’). 
This points at the possibility that TJ adaptor proteins, but not adhesion receptors, can form non-
junctional phase-separated clusters within the YSL. Our findings also suggest that ZO-1b can form 
phase-separated clusters even when it lacks its ABR, suggesting that actin binding is not a 
prerequisite for ZO-1b to undergo phase separation. However, actin binding seems to be important 
for ZO-1b clusters to take their characteristic elongated rod-like shapes, an effect most likely due to 
those clusters adhering and spreading on the filamentous actin network. Further, the presence of a 
functional actomyosin network appears to restrict the maximum size of ZO-1b clusters, consistent 
with previous studies showing that the mesh size of elastic polymers can tune the phase separation 
capacity (Style et al. 2018).  
 
Besides influencing the shape of ZO-1b clusters, binding to actin also appears to be critical for ZO-1b 
mechanosensation, given that ZO proteins that lack their ABR within the C-terminus, such as ZO-
1bΔABR, failed to respond to changes in actomyosin tension. This loss of mechanosensitivity is likely 
due to ZO-1bΔABR clusters being less effectively incorporated into TJ, an effect presumably caused 
by ZO-1bΔABR clusters being less confined to the surface of the YSL and thereby flowing below the 
TJ without being integrated. Additionally, ZO-1bΔABR showed reduced junctional stability with 
clusters frequently dissociating from the EVL-YSL junction. Interestingly, ZO-1 lacking its ABR has 
previously found to display reduced junctional immobilization (Yu et al. 2010), supporting the view 
that actin binding promotes the stable junctional incorporation of ZO-1. Furthermore, our 
observation that the retrograde flow of ZO-1bΔABR clusters within the YSL was largely unaffected 
suggests that ZO-1 binding to actin is predominantly required for localizing non-junctional ZO-1 
clusters to the YSL surface and not transporting it towards the EVL-YSL boundary. How the 
retrograde flow of non-junctional ZO-1 clusters within the YSL is achieved is not yet entirely clear, 
but it is conceivable that advection of the YSL cytoplasm caused by the flow of the actomyosin 
network might be involved. 
 
TJ mechanosensitivity is likely to be important for both junctional signaling and mechanics at the 
EVL-YSL boundary. Foremost, it might be required for triggering the formation and maturation of the 
contractile actomyosin band within the YSL by establishing a positive feedback loop, where 
actomyosin contractility and flow promotes TJ formation (Zihni et al. 2016), and TJ promote 
actomyosin contractility and flow. Our observation that TJ and actomyosin ring formation at the EVL-
YSL boundary are interdependent processes, clearly supports this notion. Interestingly, we have only 
detected retrograde actomyosin and TJ protein flows towards the EVL-YSL junction on the side of the 
YSL, but not at the leading edge of EVL forming the other side of the contact. While this might be 
due to technical limitations in imaging such flows in EVL cells that are much smaller than the yolk 
cell, it is also conceivable that TJ mechanosensitivity is restricted to the side of the YSL. How such 
potential asymmetric mechanosensitive regulation of TJ at the EVL-YSL boundary affects the 
biochemical and mechanical function of this junction is not yet clear, but binding of adhesion 
receptors over the contact might trigger non-autonomous effects eventually equilibrating the 
amount of TJ components on both sides of the EVL-YSL boundary. 
 
TJ mechanosensitivity might also be required for TJ mechanically linking the EVL margin to the YSL by 
balancing the coupling strength of TJ to the mechanical force applied to this junction by the 
contractile actomyosin network within the YSL. Such function has been demonstrated for AJ where 
junctional tension leads to conformational changes of α-catenin and vinculin, which again increases 
the actin-binding capability of these AJ components to the adjacent actomyosin cortex (Gomez, 
McLachlan, and Yap 2011). While the role of TJ in regulating cell-cell coupling strength remains 
largely unknown, recent studies showing that the TJ component ZO-1 modulates tension at cell-cell 
junctions (Tornavaca et al. 2015; Hatte, Prigent, and Tassan 2018) and can be stretched by tension 
(Spadaro et al. 2017), suggest that ZO proteins are involved in force transduction and reception at 
cell-cell contacts (Hashimoto et al. 2019). Our observation that TJ appear to be the predominant 
junction type at the EVL-YSL boundary, and that there is force transduction from the actomyosin 
band within the YSL to the leading edge of the EVL (Behrndt et al. 2012) point at the possibility that 
TJ have a force-transducing function. Whether and how forces are being transmitted by TJ, and how 
mechanosensitive junction growth affect such potential function remains to be investigated. 
 
Interestingly, previous studies have suggested that the C-terminus of ZO-1 can fold back on its N-
terminal part in an auto-inhibitory fashion, and that this auto-inhibition can be released by ZO-1 
binding to and being stretched by the contractile actomyosin network, thereby allowing it to bind to 
other junctional proteins (Spadaro et al. 2017). This might explain why versions of ZO-1b lacking 
either their ABR or entire C-terminus are unable to rescue the epiboly phenotype of zo-1b/3 YSL 
morphant embryos: their failure to directly bind to the actin cytoskeleton might not only diminish 
their localization to the YSL surface and thus their effective incorporation into TJ at the EVL-YSL 
boundary, but might also interfere with tension-induced conformational changes of ZO-1b required 
for its biological activity. Future experiments aimed at a systematic structure-function analysis of 
different ZO proteins will be needed to determine which regions, in addition to the ABR within the C-
terminus, binding directly or indirectly to the actin cytoskeleton, are needed to confer 
mechanosensitivity to those proteins. It will also be interesting to investigate how phase separation 
at the membrane is initiated - whether clusters form spontaneously through random fluctuations or 
through pre-existing structures leading to heterogeneous nucleation events (Hyman, Weber, and 
Jülicher 2014), or whether there is any additional fine-tuning of critical concentration levels or phase 
separation capacity via post-translational modifications (Alberti 2017; Monahan et al. 2017) of ZO 
proteins. 
 
There is increasing evidence for mechanochemical feedback loops forming the basis of various 
developmental processes (Goehring and Grill 2013; Hannezo and Heisenberg 2019). A key feature of 
those feedback loops is the interdependency of mechanical and chemical signals, the concerted 
action of which drive key cellular processes, such as cell polarization and migration. While the 
biochemical basis of force-generation and transmission is increasingly well understood (Lecuit, 
Lenne, and Munro 2011), comparable little is yet known about how mechanical forces feed back on 
biochemical processes. Our findings of mechanical forces promoting the growth of TJ through the 
generation of actomyosin flow not only unravels that TJ, similar to AJ, are mechanosensitive, but 
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Figure 1. Tight junction components accumulate at the EVL-YSL boundary 
(A) Schematic representation of enveloping layer (EVL) spreading during consecutive stages of 
epiboly (4-5, 6 and 8 hpf). Yolk cell, light grey; blastoderm (EVL and deep cells), dark grey. Black 
rectangle demarcates region of enlarged sagittal view outlining the tissue structure at 8 hpf. Red 
rectangle demarcates regions of the EVL-YSL boundary shown in (B).  
(B) Maximum intensity projections (MIPs) of F-actin (Phalloidin, 1st row), ZO-1 (2nd row), ZO-3 (3rd 
row), E-Cadherin (4th row), and β-Catenin (5th row) localization at the EVL-YSL boundary at 4-5 hpf 
(left column), 6 hpf (middle column) and 8 hpf (right column). ZO-1, ZO-3, E-Cadherin and β-Catenin 
were detected by immunohistochemistry. White arrowheads point to increased accumulation at the 
EVL-YSL boundary. Scale bar, 20 µm. 
(C) Plot of EVL-YSL junctional intensity normalized to EVL-EVL junctional intensity as a function of 
time during EVL epiboly (see also schematic above). Data are mean at 95% confidence. F-actin with 
N=2 and n=15 cells at 4-5 hpf, n=42 cells at 6 hpf and n=46 cells at 8 hpf. ZO-1 with N=2 and n=15 
cells at 4-5 hpf, n=42 cells at 6 hpf and n=46 cells at 8 hpf. ZO-3 with N=2 and n=26 cells at 4-5 hpf, 
n=52 cells at 6 hpf, n=58 cells at 8 hpf. E-Cadherin with N=3 and n=29 cells at 4-5 hpf, with N=2 and 
n=32 cells at 6hpf, N=3 and n=84 cells at 8 hpf. β-Catenin with N=2 and n=54 cells at 4-5 hpf, n=29 
cells at 6 hpf, n=28 cells at 8 hpf.  
(D) Plot of EVL-YSL junctional intensity (black) and EVL-EVL junctional intensity (grey) normalized to 
cytoplasmic intensity at 8hpf. Red dashed line indicates ratio of 1 demarcating the boundary between 
accumulation (>1) and depletion (<1). Data are mean at 95% confidence. F-Actin and ZO-1 with N=2 
and n=46 cells, ZO-3 with N=2 and n=58 cells. E-Cadherin with N=2 and n=40 cells. β-Catenin with 
N=2 and n=28 cells. Statistical test for F-Actin, ZO-3 and E-Cadherin, Mann-Whitney test with ****p < 
0.0001; ZO-1 and β-Catenin, Unpaired t test with ****p < 0.0001.  
See also Figure S1. 
 
Figure 2. ZO-1b and 3 are required for proper EVL epiboly movements, and actomyosin flows 
and tension within the YSL 
(A,B) Maximum intensity projections (MIPs) of brightfield/fluorescence images of embryos injected 
directly into the YSL at high stage (3.3 hpf) with phenol red and H2A-mcherry mRNA (Ctrl, left panel), 
zo-1b MO (1.5 ng) and zo-3 MO (0.5 ng) (middle panel), and zo-1b/3 MO together with GFP-tagged 
zo-1b mRNA (25 pg) and GFP-tagged zo-3 mRNA (mutated for MO recognition site, 5 pg) (right 
panel) at 9 hpf (A) and wild-type (wt) control embryos (Ctrl, left panel), MZzo-1b/3 mutant (middle 
panel) and morphant embryos (injected with 1.5 ng of zo-1b MO and 0.5 ng of zo-3 MO at 1-cell 
stage, right panel) at 9 hpf (B). Plasma membrane is marked by membrane-RFP to outline cells. EVL-
YSL boundary is marked by white dashed line to demarcate extent of EVL epiboly in the different 
conditions. Schemes of different injection methods showing injection into the YSL (A) to obtain YSL-
specific knock-down and into the 1-cell stage embryo (B) to gain ubiquitous knock-down. Scale bar, 
200 µm. 
(A’, B’) Plot of total time required for EVL to complete epiboly for the conditions shown in (A,B) and 
normalized to average time needed by control embryos. (A’) YSL-Ctrl in black with N=3, n=11 
embryos; YSL-morphant in cyan with N=3, n=12 embryos; and YSL morphant rescue in magenta with 
N=3, n=11 embryos. (B’) wt control in black with N=4, n=11 embryos and 1-cell stage injected controls 
in black for morphant with N=3, n=11 embryos; mutant in cyan with N=4, n=13 embryos, and 
morphant in magenta with N=3, n=8 embryos. Data are shown as box-and-whisker plots (Whiskers: 
Tukey). Ordinary one-way ANOVA with Tukey’s multiple comparisons test with ****p < 0.0001, ***p < 
0.001 (A’) and one-way ANOVA with Tukey’s multiple comparisons test ****p < 0.0001 (B’). 
(A’’,B’’) Plot of EVL tissue spreading, expressed as height of EVL (hEVL ) normalized to 
total embryo height (hTOT ), as a function of time normalized to average time needed by control 
embryos for the conditions shown in (A,B). N/n as in (A’,B’). Data are mean ± s.e.m. 
(C) MIPs of Myosin-2 localization at the EVL-YSL boundary in Tg(actb1:myl12.1-eGFP) or 
Tg(actb1:myl12.1-mcherry)  YSL-Ctrl (phenol red injected), zo-1b/3 YSL-morphant (1.5ng, 0.5 ng into 
the YSL) and zo-1b/3 YSL-morphant embryos rescued by co-injection of GFP-tagged zo-1b (25 pg) 
and zo-3 (5 pg, mutated for MO recognition site) mRNAs at 7-8 hpf. Scale bar, 20µm. 
(C’) Plot of Myosin-2 intensity as a function of distance from EVL margin in YSL-Ctrl, zo-1b/3 YSL-
morphant and rescued zo-1b/3 MO YSL-morphant embryos at 7-8 hpf. Fluorescence intensity was 
normalized to EVL cortical signal. Data are mean ± s.e.m. Unpaired t test with **p = 0.0012 and 
*p=0.0329. YSL-Ctrl with N=4, n=8 embryos and zo-1b/3 YSL-morphant with N=5, n=8 embryos. 
Rescued zo-1b/3 YSL-morphant with N=6, n=13 embryos.  
(D) Kymograph of Myosin-2 flow velocities along the animal-vegetal (AV) axis of the embryo as a 
function of time during epiboly in an exemplary YSL-Ctrl, zo-1b/3 YSL-morphant and zo-1b/3 rescued 
YSL-morphant embryo at 7-8 hpf. Kymograph ranges from negative values (in blue and blue arrow) 
indicating retrograde flows towards the EVL margin to positive values (in red and red arrow) indicating 
anterograde flows towards the vegetal pole. Black dashed line indicates the slope of EVL movement 
of YSL-Ctrl embryos; EVL is located above dashed line and YSL below. Blue dashed line indicates 
EVL movement of zo-1b/3 YSL-morphant embryo and pink dashed line indicates EVL movement of 
rescued zo-1b/3 YSL-morphant embryo. 
(D’) Plot of Myosin-2 mean flow velocities along AV axis averaged over 7.5-30 min in YSL-Ctrl, zo-
1b/3 YSL-morphant and rescued zo-1b/3 YSL-morphant embryos between 7 and 8 hpf. EVL peak 
velocities averaged over 10 µm, Unpaired t test, ****p < 0.0001; YSL peak velocities averaged over 45 
µm (15 - 60 µm from EVL margin), Mann-Whitney test , ****p < 0.0001. N/n same as in (C’’). 
(E,F) MIPs of the EVL-YSL boundary in Myosin-2 expressing Tg(actb1:myl12.1-eGFP) YSL-Ctrl and 
zo-1b/3 YSL-morphant (1.5 ng of zo-1b MO and 0.5ng of zo-3 MO into the YSL) embryos at 7-8 hpf 
(E) and Tg(actb1:myl12.1-eGFP) expressing wt embryos at 6 and 8 hpf (F), after (4th post-cut frame) 
UV laser-cutting along a 5 µm line oriented perpendicular to the boundary. Scale bar, 10 µm. 
(E’,F’) Exemplary kymographs of EVL-YSL junctional opening in response to UV-laser cutting as a 
function of time for the conditions shown in (E,F). Horizontal scale bar, 1.2 s; vertical scale bar, 1 µm. 
(E’’,F”) Plot of initial recoil velocities of EVL-YSL junction after UV-laser cutting for the conditions 
shown in (E,F). Data are shown as box-and-whisker plots (whiskers: Tukey). Unpaired t test with ****p 
< 0.0001;  **p = 0.0073. YSL-Ctrl and zo-1b/3 YSL-morphant with each N=2, n=12 embryos. wt 
embryos at 6 hpf and 8 hpf with each N=3, n=17 embryos. 
See also Figure S2 and Videos S1 and S2.  
 
Figure 3. Actomyosin contractility affects ZO-1 recruitment to the EVL-YSL boundary 
(A,B) Maximum intensity projections (MIPs) of F-actin (Phalloidin, 1st row) and ZO-1 (2nd row) 
localization at the EVL-YSL junction in embryos that were either injected into the YSL at high stage 
(3.3 hpf) with H2A-mcherry mRNA (100pg, left column, Ctrl) and caMypt mRNA (75pg caMypt plus 
25pg H2A-mcherry mRNA, right column) shown at 8 hpf (A), or injected into marginal 
blastomeres/YSL at 128-cell stage with H2B-EGFP mRNA (2.3-2.5 pg - left column, Ctrl) and caRhoA 
mRNA (0.3-0.5 pg caRhoA plus 2 pg H2B-GFP, right column) shown at 6 hpf (B). ZO-1 was detected 
by immunohistochemistry. White arrowheads point to decrease (A) or increase (B) in signal at the 
EVL-YSL boundary. Scale bar, 20 µm. 
(A’,B’) Plot of junctional ZO-1 intensity ratio (EVL-YSL/EVL-EVL) for the conditions described in (A,B). 
(A) Ctrl with N=2, n=44 cells; caMypt mRNA YSL-injected embryos with N=2, n=39 cells. (B) Ctrl YSL-
injected embryos with N=2, n=28 cells; caRhoA mRNA YSL-injected with N=2, n=52 cells. Data are 
shown as mean plus s.e.m.; Mann-Whitney test; ** p = 0.006 (A’), ***p = 0.0007 (B’).  
(A”,B”) Plot of non-junctional ZO-1 fluorescent intensity as a function of distance from the EVL margin 
for the conditions shown in (A,B). Data are shown as mean plus s.e.m. Unpaired t test of non-
junctional pool within first 5 µm from EVL margin with ****p  < 0.0001 (A). Mann-Whitney test of non-
junctional ZO-1 within first 5 µm from EVL margin with ****p  < 0.0001 (B). (A’’) Ctrl with N=2, n=6 
embryos; caMypt with N=2,n=7 embryos. (B’’) Ctrl with N=2, n=6 embryos; caRhoA with N=2, n=9 
embryos.  
See also Figure S3. 
Figure 4. Non-junctional clusters of ZO-1b within the YSL undergo retrograde flows and are 
incorporated into TJ at the EVL-YSL boundary 
(A,B) Maximum intensity projections (MIPs) of Myosin-2 (A) or ZO-1b (B) localization at the EVL-YSL 
boundary in Tg(actb1:myl12.1-mcherry; actb1:mNEONgreen-zo-1b) embryos at 7-8 hpf. Scale bar, 20 
µm.  
(A’,B’) Exemplary kymographs of Myosin-2 (A’) or ZO-1b (B’) flow velocities along the animal-vegetal 
(AV) axis of the YSL as a function of time during epiboly. Kymograph ranges from negative 
(retrograde flows towards the EVL-YSL boundary, blue) to positive (anterograde flows away from the 
EVL-YSL boundary, red) values. 
(A’’,B’’)  Maximum Myosin-2 (A”) and ZO-1b (B”) flow velocities, indicating peak retrograde flow rates 
within the YSL (negative value) and maximum epiboly movement velocity of the EVL-YSL boundary 
(positive value). N=4, n=7 embryos. Mann-Whitney test, ns not significant. 
(C) Consecutive MIP high-resolution (Airy Scan) images of non-junctional ZO-1b being incorporated 
at the EVL-YSL boundary (indicated by white arrow head) in a Tg(actb1:mNEONgreen-zo-1b) embryo 
at 7-8 hpf. Horizontal scale bar, 48 sec; Vertical scale bar, 2 µm. Calibration bar showing LUT for grey 
value range. 
(C’) Kymograph of boxed region in (C) showing non-junctional ZO-1b cluster (black arrowhead) 
incorporation at the EVL-YSL boundary (pink arrowhead). Horizontal scale bar, 40 sec; vertical scale 
bar, 1 µm.  
(D) Consecutive MIP high-resolution (Airy Scan) images of non-junctional ZO-1b clusters undergoing 
fusion close to the EVL-YSL boundary (within 15 µm distance to EVL) in a Tg(actb1:mNEONgreen-
zo-1b) embryo at 6.5-8 hpf. White dashed circle shows region of fusing non-junctional clusters. Scale 
bar, 500 nm. Calibration bar showing LUT for grey value range. 
(D’) Plot of average ZO-1b non-junctional cluster size normalized to initial average size within the YSL 
as a function of time between 5.7-8 hpf. Cluster size was averaged over acquisition times of 20 sec 
+/- 5.5 s. N=5, n=9 embryos.  
(D’’) Plot of cumulative fusion events per ZO-1b cluster as a function of time in 
Tg(actb1:mNEONgreen-zo-1b) embryos at 6-8 hpf. Each line represents fusion events averaged per 
embryo. N=5, n=15 embryos. 
(E,F) Sum intensity projection image (sum of all slices) of ZO-1b signal in Tg(actb1:mNEONgreen-zo-
1b) embryos within the YSL (2-5 µm from EVL margin) (E with N=4, n=13 embryos and F with N=4, 
n=12 embryos) after bleaching in FRAP experiments at early-mid (5-6 hpf; E) and late epiboly stage 
(7-8 hpf; F). White dashed box outlines bleached region. Scale bar, 5 µm. 
(E’,F’) Exemplary kymograph of bleached region for the conditions described in (E,F). White dashed 
box outlines region used for intensity measurements. Horizontal scale bar, 40 s; vertical scale bar, 1 
µm. 
(E”,F”) Plot of GFP-ZO-1b fluorescence recovery as a function of time for the conditions described in 
(E,F). Data are mean ± SD. Intensity values were normalized to the pre-bleach intensities and to non-
junctional signals (E,F) to correct for bleaching (more details see Materials and Methods). Solid line 
shows a double exponential fit (E’’,F’’).  
See also Figure S4 and Videos S3 and S4.  
 
Figure 5. Non-junctional ZO-1b undergoes phase separation within the YSL 
(A) MIP high-resolution (Airy Scan) images of non-junctional GFP-ZO-1b clusters within the YSL of 
MZzo-1b/3 mutants injected at 1-cell with different concentrations of GFP-zo-1b mRNAs (50 pg - 150 
pg mRNA) at 7-8 hpf. 1st row, GFP signal only; 2nd row, GFP signal (green) overlaid with white signal 
obtained by cluster masking using Ilastik (for details see Materials and Methods). ZO-1b 
concentrations in µM were determined via quantitative fluorescence microscopy. Calibration curves 
(see Figure S5A) were acquired with the same imaging settings. Intensity for image of 1 µM ZO-1b 
concentration was enhanced for displaying the small and less intense clusters better. Scale bar, 2 µm.  
(A’) Plot of average area of ZO-1b clusters as a function of ZO-1b concentration. N=3, n=33 embryos.  
(A’’) Bar plot of average fusion rate per ZO-1b cluster for different ZO-1b concentrations within the 
YSL. Average fusion rate was determined as the total fusion number divided by the average cluster 
number in a time window of 3 min. Data are shown as box-and-whisker plots (Whiskers: Tukey).  
Mann Whitney test. ***p = 0.001. N=3, n=32 embryos. 
(A’’’) Plot of cumulative fusion events per ZO-1b cluster as a function of time. Curves show the 
different ZO-1b concentrations. Data are shown as mean plus s.e.m. N/n see (A’’). 
(B) Schematic representation of the domain structure of full length ZO-1b, ZO-1bΔC construct, lacking 
its mainly intrinsically disordered C-terminus including an Actin binding region (ABR) and ZO-1bΔABR 
construct, only lacking the ABR within the IDR.  
(C) MIP high-resolution (Airy Scan) images of MZzo-1b/3 mutant embryos injected at 1-cell stage with 
either GFP-zo-1b (50 pg, Ctrl) or GFP-zo-1bΔC (30 pg) mRNAs at 8 hpf. Scale bar, 2 µm. 
(D,E) MIP high-resolution (Airy Scan) images of non-junctional ZO-1b clusters within the YSL of 
MZzo-1b/3 mutants injected at 1-cell stage with either GFP-zo-1b (50 pg, control) or GFP-zo-1bΔABR 
(44 pg) at 7-8 hpf (D). MIP high-resolution (Airy Scan) images of Tg(actb1:mNEONgreen-zo-1b) 
embryos treated for 1h with either DMSO (Ctrl) or 1 µg/ml Latrunculin B prior to imaging at 5.3-6.3 hpf 
(E). 1st row, GFP signal only; 2nd row, GFP signal (green in D or white in E) overlaid with white (D) or 
red (E) signal obtained by cluster masking using Ilastik (for details see Materials and Methods). Scale 
bar, 2 µm. 
(D’) Bar plot of average fusion rate per ZO-1b and ZO-1bΔABR cluster within the YSL. Average fusion 
rate was determined as the total fusion number divided by the average cluster number in a time 
window of 3 min. Data are shown as box-and-whisker plots (Whiskers: Tukey); Mann Whitney test; ns. 
not significant. ZO-1b with N=4, n= 8 embryos. ZO-1bΔABR with N=4, n=12 embryos. 
(D’’) Plot of cumulative fusion events per cluster as a function of time for ZO-1b and ZO-1bΔABR. 
Data are shown as mean plus s.e.m. N/n see (D’). 
(D’’’,E’) Bar plot of average ZO-1b cluster area for the conditions described in (D and E). Data are 
shown as box-and-whisker plots (Whiskers: Tukey). Average Area of (D’’’) with unpaired t test, ns, not 
significant, p=0.0924. GFP-ZO-1b with N=6, n=9 embryos;  GFP-ZO-1bΔABR with N=5, n=14 
embryos. Average area of (E’) with unpaired t test, *p = 0.0121. DMSO Ctrl with N=4, n=8 embryos; 
LatB with N=4, n=9 embryos. 
(D’’’’,E’’) Bar plot of average ZO-1b cluster circularity for the conditions described in (D and E). 
Circularity of clusters above 0.15 µm2 area were analyzed. Data are shown as box-and-whisker plots 
(Whiskers: Tukey). A circularity value of 1 reflects a perfect circle, while values close to 0 indicate 
more elongated shapes. Circularity of (D’’’’) with unpaired t test *p = 0.0332. GFP-ZO-1b with N=6, 
n=9 embryos;  GFP-ZO-1bΔABR with N=5, n=12 embryos. Circularity of (E’’) with Mann-Whitney test, 
***p=0.0004. DMSO Ctrl with N=4, n=6 embryos; LatB with N=4, n=9 embryos.  
(F) Consecutive MIP high-resolution (Airy Scan) images of ZO-1b clusters undergoing fusion within 
the YSL of Tg(actb1:mNEONgreen-zo-1b) embryos treated for 1h with 1 µg/ml Latrunculin B prior to 
imaging at 5.3-6.3 hpf. Scale bar, 1 µm. 
See also Figure S5 and Video S5. 
 
Figure 6. Mechanosensitive response of ZO-1b is dependent on its C-terminus 
(A,B,C) Maximum intensity projections (MIPs) of GFP-tagged ZO-1b (50 pg) (A), GFP-tagged ZO-
1bΔC (30 pg) (B) and GFP-tagged ZO-1b-ΔABR (44 pg) (C) localization at the EVL-YSL boundary in 
MZzo-1b/3 embryos injected with H2A-mCherry mRNA (Ctrl - 2.3-2.5 pg H2A-mCherry; A with N=5, 
n=23 cells; B with N=4, n=43 cells; C with N=3, n=17 cells; two columns on the left) and embryos 
injected with caRhoA mRNA (0.3-0.5 pg caRhoA plus 2 pg H2B-GFP) specifically within the YSL (A 
with N=3, n=19 cells; B with N=3, n=13 cells; C with N=3, n=27 cells; two columns on the right) at the 
onset of imaging (7 hpf) (0 min; 1st and 3rd column) and 24 min later (2nd and 4th column). White 
arrowhead points to increased accumulation at the EVL-YSL boundary. Scale bar, 10 µm. 
(A’,B’,C’) Plot of EVL-YSL junctional intensity normalized to EVL-EVL junctional intensity as a function 
of time during EVL epiboly in the conditions described in (A,B,C). Data are mean ± s.e.m. 
(D,E) MIPs of brightfield/fluorescence images of embryos injected directly into the YSL at high stage 
(3.3 hpf) with phenol red and H2A-mcherry mRNA (Ctrl in D with N=8, n=27 embryos, Ctrl in E with 
N=3, n=10 embryos), zo-1b/3 MO (1.5 ng zo-1b MO, 0.5ng zo-3 MO, D with N=8, n=28 embryos; E 
with N=3, n=12 embryos) alone, zo-1b/3 MO together with GFP-zo-3 (5 pg) and GFP-zo-1b (25 pg) 
mRNA (D with N=8, n=27 embryos; E with N=3, n=8 embryos), and zo-1b/3 MO together with GFP-
zo-3 (5 pg) and GFP-zo-1bΔC (15 pg) mRNA (D with N=8, n=26 embryos) or zo-1b/3 MO together 
with GFP-zo-3 (5 pg) and GFP-zo-1bΔABR (22 pg) mRNA (E with N=3, n=8 embryos) at 9 hpf. 
Plasma membrane is marked by membrane-RFP to outline cells. EVL-YSL boundary is marked by 
white dashed line to demarcate extent of EVL epiboly in the different conditions. Scale bar, 100 µm. 
(D’,E’) Plot of total time required for EVL to complete epiboly for the conditions shown in (D,E) and 
normalized to average time needed by control embryos. Data are shown as box-and-whisker plots 
(Whiskers: Tukey). One-way ANOVA with ****p < 0.0001; **p=0.0027; ns, non significant. For full-
length rescue (Figure 6D-D’) , data shown in Figure 2B’ were included. 
See also Figure S5, S6 and Video S6. 
 
  
Figure S1. Tight junction and adherens junction component accumulation at the EVL-YSL 
boundary. Related to Figure 1. 
(A) Schematic representation of EVL spreading during consecutive stages of epiboly (4-5, 6 and 8 
hpf). Yolk cell, light grey; blastoderm (EVL and deep cells), dark grey. Red rectangle demarcates 
regions of the EVL-YSL boundary shown in (B). 
(B) Maximum intensity projections (MIPs) of GFP-Cingulin-like 1 (1st row), GFP-Claudin-D (2nd row), 
GFP-Occludin-A (3rd row) and α-Catenin (4th row) localization at the EVL-YSL boundary at 4-5 (left 
column), 6 (middle column) and 8 (right column) hpf. α-Catenin is visualized by 
immunohistochemistry, Cingulin-like 1 and Claudin-D and Occludin-A by expression of their 
respective GFP- or mNEONgreen-fusion constructs, respectively, in wild type embryos injected with 
15 - 50 pg mRNA at 1-cell stage. White arrowheads point to increased accumulation at the EVL-YSL 
boundary. Scale bar, 20 µm.  
(C) Plot of EVL-YSL junctional intensity normalized to EVL-EVL junctional intensity as a function of 
time during EVL epiboly (see also schematic above). Data are mean at 95% confidence. Cingulin-like 
1 with N=2 and n=33 cells at 4-5 hpf, n=37 cells at 6 hpf and n=31 cells at 8 hpf. Claudin-D with N=2, 
n=40 cells at 4-5 hpf, n=50 cells at 6 hpf, n=29 cells at 8 hpf. Occludin-A with N=2, n=27 cells at 4-5 
hpf; N=2, n=54 cells at 6 hpf; N=3, n=43 cells at 8 hpf. α-Catenin with N=2 and n=45 cells at 4-5 hpf, 
n=29 cells at 6 hpf, n=28 cells at 8 hpf.  
(D) Plot of EVL-YSL junctional intensity (black) and EVL-EVL junctional intensity (grey) normalized to 
cytoplasmic intensity at 8 hpf. Red dashed line indicates ratio of 1 demarcating the boundary between 
accumulation (>1) and depletion (<1). Data are mean at 95 % confidence. Cingulin-like 1 with N=2 
and n=30. Claudin-D with N=2 and n=29 cells. Occludin-A with N=3, n=43 cells. α-Catenin with N=2 
and n=28 cells. Cingulin, Claudin-D and Occludin-A with Mann-Whitney test with **p = 0.0073, ns, not 
significant; α-Catenin, Unpaired t test with ****p < 0.0001.  
 
Figure S2. zo-1b/3 mutant and morphant analysis. Related to Figure 2. 
(A) Plot of total time required for EVL to complete epiboly normalized to the average time needed by 
control embryos injected with either phenol-red (Ctrl), zo-1b/3 5-base mismatch control MO (zo-1b/3 
MO) or standard negative control MO (standard control MO) into the YSL. Data are mean ± s.e.m. 
Kruskal-Wallis test with Dunn’s multiple comparisons test. ns, not significant. Ctrl with N=4, n=14 
embryos; zo-1b/3 MO with N=3, n=12 embryos; standard control MO with N=3, n=11 embryos.  
(B) Dorsal view of YSL-injected control (phenol-red, YSL-Ctrl) and zo-1b/3 morphant (YSL-morphant) 
embryos at 1-somite stage (10.5 hpf) labeled by in situ hybridization for papc outlining the forming 
somites. Scale bar, 200 µm. 
(B’) Bar plot of stage distribution (categorized in 0 and 1 somite stages as revealed by papc in situ 
hybridization) for the conditions described in (B). Data are mean ± s.e.m. 80% of Ctrl-YSL embryos 
and 69% of zo-1b/3 YSL-morphants showed 1 somite at 10.5 hpf. Mann-Whitney test with n.s.; not 
significant. YSL-Ctrl with N=3, n=36 embryos; YSL-morphant with N=3, n=45 embryos;  
(C) Mutation sites in MZzo-1b and MZzo-3 mutants. Red triangles indicate the insertion sites of the 
STOP codon. 
(D) Plot of EVL tissue spreading, expressed as height of EVL (hEVL ) normalized to total embryo height 
(hTOT ), as a function of time normalized to average time needed by control embryos shown for wild-
type (wt) control, and MZzo-1b and MZzo-3 single mutants. Data are mean ± s.e.m. One-way ANOVA 
with Tukey’s multiple comparisons test. ns. not significant. Wt (Ctrl) with N=4, n=27 embryos; MZzo-
1b with N=3, n=16 embryos; and MZzo-3 with N=3, n=18 embryos.  
(E) Dorsal view of control (phenol-red, Ctrl) and zo-1b/3 morphant embryos (morphant) injected at the 
one-cell stage, and of wild-type (wt) and MZzo-1b/3 mutant embryos labeled at 10.5 hpf by in situ 
hybridization for papc outlining the forming somites.  Scale bar, 200 µm. 
(E’) Bar plot of stage distribution (categorized in 0, 1 and 2-somite stages as revealed by papc in situ 
hybridization) for the condition described in (E). 86% of Ctrl, 67% of MZzo-1b/3 embryos and 73% of 
zo-1b/3 morphants showed 1 somite  at 10.5 hpf. Data are mean ± s.e.m. Cumulative link mixed 
model (Christensen 2018) was used to determine p-values in R. Ctrl vs. MZzo-1b/3 mutants with p = 
0.0002 and Ctrl vs. zo-1b/3 morphants with p = 0.04. Ctrl with N=2, n=26 embryos; morphant with 
N=3, n=43 embryos; wt Ctrl with N=4, n=72 embryos and mutant with N=5, n=77 embryos. 
(F) Maximum intensity projections (MIPs) of ZO-1 (left column), ZO-3 (middle column) and E-cadherin 
(right column) localization at the EVL-YSL boundary in YSL-Ctrl (upper row) and zo-1b/3 YSL-
morphant (lower row) embryos at 8 hpf. ZO-1, ZO-3 and E-Cadherin were detected by 
immunohistochemistry. Scale bar, 20µm. 
(F’) Plot of EVL-YSL junctional intensity normalized to EVL-EVL junctional intensity at 8 hpf for the 
conditions described in (F). Data are mean ± s.e.m. Statistical test for ZO-1 intensity with Mann-
Whitney test, ****p < 0.0001; ZO-3 intensity with unpaired t test, ****p < 0.0001; and E-Cadherin 
intensity with unpaired t test with **p = 0.0029; ZO-1: N=2, YSL-Ctrl with n=30 cells and zo-1b/3 YSL-
morphant with n=40 cells; ZO-3: N=2, YSL-Ctrl with n=42 cells and zo-1b/3 YSL-morphant with n=59 
cells. E-Cadherin: N=3, Ctrl with n=51 cells and zo-1b/3 YSL-morphant with n=54 cells.  
(G) MIPs of ZO-1 (left column), ZO-3 (middle column) and F-actin (right column) localization at the 
EVL-YSL boundary in wt (upper row - Ctrl) and MZzo-1b/3 mutant (lower row) embryos at 8 hpf. ZO-1 
and ZO-3 were detected by immunohistochemistry, and F-actin by Phalloidin. ZO-1 antibody likely 
detects both zebrafish ZO-1a and ZO-1b, suggesting that the remaining signal in the MZzo-1b/3 
mutant reflects ZO-1a protein expression. 
(G’) Plot of EVL-YSL junctional intensity normalized to EVL-EVL junctional intensity, and EVL-YSL 
junctional intensity together with EVL-EVL junctional intensity normalized to cytoplasmic intensity at 8 
hpf for the conditions shown in (G). Data are mean ± s.e.m. Statistical test for ZO-1: EVL-YSL/EVL-
EVL with Mann-Whitney test ****p < 0.0001, and EVL-YSL/cyto and EVL-EVL/cyto with unpaired t-test 
with ****p < 0.0001; ZO-3: EVL-YSL/cyto and EVL-EVL/cyto with unpaired t-test with ****p < 0.0001. 
N=2, wt with n=31 cells and MZzo-1b/3 mutant with n=33 cells.  
(G’’) Plot of F-Actin fluorescence intensity within the YSL as a function of distance from EVL margin 
for the conditions described in (D). F-actin was detected by Phalloidin. [a.u.], arbitrary units. N=2, wt 
with n=7 embryos and MZzo-1b/3 mutant with n=7 embryos. 
(H) Compensatory expression changes of zo genes in MZzo-1b/3 mutant embryos normalized to the 
expression level of a housekeeping gene (elongation factor 1α). Fold change reflects the relative 
change of expression levels in MZzo-1b/3 mutant compared to wt embryos in qRT-PCR. Red solid 
line indicates 1-fold change in expression, demarcating the boundary between increase (>1) and 
decrease (<1) of expression levels of the five different zo genes (N=3). 
(I,J) Plot of junctional opening (distance in µm) of the EVL-YSL boundary marked by Myosin-2-GFP 
after UV laser cutting at late (8 hpf) stage of EVL epiboly in YSL-Ctrl and zo-1b/3 YSL-morphant (I) 
embryos and in wt embryos (J) at mid (6 hpf) and late (8 hpf) stages of EVL epiboly as a function of 
time after cutting. Red dashed boxes indicate regions for calculation of initial recoil velocity shown in 
(I’,J’). 
(I’,J’) Plot of the first four time-points from (I,J) with linear fit to extract initial recoil velocity shown in 
(Figure 2E’’, 2F’’). N,n see (Figure 2E-F).  
 
Figure S3. Effects of actomyosin contractility on its flow rate and AJ protein recruitment to 
EVL-YSL boundary. Related to Figure 3.  
(A,C) MIPs of Myosin-2 localization at the EVL-YSL boundary in Tg(actb1:myl12.1-eGFP) embryos 
that were either injected into the YSL at high stage (3.3 hpf) with caMypt mRNA (75pg caMypt plus 
25pg H2A-mcherry mRNA, right column) shown at 8 hpf (A), or injected into marginal 
blastomeres/YSL at 128-cell stage with H2A-mcherry mRNA (2.3-2.5 pg) and caRhoA mRNA (0.3-0.5 
pg caRhoA mRNA plus 2 pg H2A-mcherry mRNA) shown at 6-7 hpf (C). Scale bar, 20 µm. 
(A’,C’) Plot of Myosin-2 intensity as a function of distance from EVL margin in caMypt (A’), Ctrl and 
caRhoA (C’) mRNA YSL-injected embryos at 7-8 hpf and 6-7 hpf, respectively. Fluorescence intensity 
was normalized to EVL cortical signal. Data are mean ± s.e.m. Mann-Whitney test with **p = 0.0031 
(A’); *p = 0.0303 (C’). For N/n of YSL-Ctrl see (Figure 2C’). caMypt mRNA YSL-injected embryos with 
N=3, n=5 (A’); Ctrl with N=2, n=6 and caRhoA mRNA YSL-injected embryos with N=3, n=5 (C’). 
(B,D) Kymograph of Myosin-2 flow velocities along the animal-vegetal (AV) axis of the embryo as a 
function of time during epiboly in an exemplary caMypt mRNA YSL-injected embryo at 7-8 hpf (B), Ctrl 
and caRhoA mRNA YSL-injected embryo 6-7 hpf (D). Kymograph ranges from negative values (in 
blue), indicating retrograde flows towards the EVL margin, to positive values (in red), indicating 
anterograde flows towards the vegetal pole. 
(B’,D’) Plot of Myosin-2 mean flow velocities along AV axis averaged over 10-30 min in caMypt mRNA 
YSL-injected embryos (B’), Ctrl (phenol-red) and caRhoA mRNA (D’) YSL-injected embryos between 
7-8 hpf and 6-7 hpf, respectively. YSL peak velocities were determined 15-60 µm from EVL margin. 
Statistical test for caMypt, Mann-Whitney test, ****p < 0.0001. Statistical test for caRhoA, Unpaired t 
test, ****p < 0.0001. N/n same as in (A’,C’). 
(E) Maximum intensity projections (MIPs) of E-Cadherin (1st row) and β-Catenin (2nd row) 
localization at the EVL-YSL boundary in uninjected control embryos (Ctrl; first column) and embryos 
injected into the YSL with caRhoA (0.3-0.5 pg caRhoA plus 2pg H2B-EGFP) mRNA at 6 hpf (second 
column). E-Cadherin and β-Catenin were detected by immunohistochemistry. Scale bar, 20µm. 
(E’) Plots of E-cadherin and β-Catenin intensities at the EVL-YSL boundary normalized to EVL-EVL 
junctional intensity for the conditions described in (E). Mann-Whitney test, ns, not significant; E-
cadherin and β-Catenin with N=2, control with n=31 cells and caRhoA mRNA YSL-injected embryos 
with n=27 cells. 
 
Figure S4. Junctional ZO-1b dynamics. Related to Figure 4. 
(A,B) Sum intensity projection image (sum of all slices) of GFP-ZO-1b signal in 
Tg(actb1:mNEONgreen-zo-1b) embryos at the EVL-YSL boundary (A with N=3, n=9 cells and B with 
N=2, n=10 cells) after bleaching in FRAP experiments at early-mid (5-6 hpf; A) and late epiboly stage 
(7-8 hpf; B). White dashed box outlines bleached region. Scale bar, 5 µm. 
(A’,B’) Exemplary kymograph of bleached region for the conditions described in (A,B). White dashed 
box outlines region used for intensity measurements. Horizontal scale bar, 40 s; vertical scale bar, 1 
µm. 
(A”,B”) Plot of GFP-ZO-1b fluorescence recovery as a function of time for the conditions described in 
(A,B). Data are mean ± SD. Intensity values were normalized to the pre-bleach intensities and to 
reference junctional signals to correct for bleaching (more details see Materials and Methods). Solid 
line shows a double exponential fit (A’’) and single exponential fit (B’’). Double exponential fit was 
used at early-mid stage (6 hpf) due to the presence of two species (fast and slow species) of ZO-1b. 




Figure S5. Interaction between ZO-1b and the actomyosin network within the YSL. Related to 
Figure 5. 
(A) Calibration curve of fluorescence intensity normalized to laser power as a function of GFP protein 
concentration. a.u., arbitrary units. 0 µM (PBS) with N=3; 1 µM with N=1; 1.25 µM with N=2; 2.5 µM 
with N=2; 5 µM with N=2; 10 µM with N=3. 
(B) Single plane fluorescence images of ZO-1b, Myosin-2 and an overlay of ZO-1b and Myosin-2 to 
visualize ZO-1b/Myosin-2 protein co-localization within the YSL of Tg(actb1:myl12.1-mcherry; 
actb1:mNEONgreen-zo-1b) embryo at 6-8 hpf. White boxes demarcate zoom-in region of examples of 
either mutual exclusive localization or co-localization of ZO-1b and Myosin-2. Scale bar, 2 µm (left 
panel) and 0.5 µm (right panel).  
(B’) Scatterplot of ZO-1b and Myosin-2 showing a wide signal spread indicative of partial 
colocalization (for more details see Material and Methods). Bar plot of Li’s Intensity Correlation 
Quotient (ICQ) for colocalization quantification of ZO-1b and Myosin-2 between 6-8 hpf. Li’s ICQ value 
ranges from 0.5 showing colocalization to -0.5 showing exclusion and values close to 0 indicate 
random localization. N=4, n=17 embryos. 
(C) Maximum intensity projections (MIPs) of ZO-1b, Myosin-2 and Actin signals within the YSL of 
Tg(actb1:myl12.1-mcherry; actb2:mNEONgreen-zo-1b) and Tg(actb2:NeonGreen-zo-1b) 
(actb2:Utrophin-mcherry) embryos exposed for 1h to DMSO (control) and 1 µg/ml Latrunculin B 
followed by imaging from 5.3 to 6.3hpf. White dashed line shows exemplary line for plot in (C’). Scale 
bar, 2 µm. 
(C’) Line plots of Myosin-2 and Actin network intensity distribution within the YSL of 3 exemplary 
embryos each treated with DMSO or Latrunculin B (LatB). Note the strong decrease in signal between 
different Myosin-2 or Actin clusters upon LatB treatment (indicated with red arrow heads). 
(D) MIPs of ZO-1b and ZO-1b-ΔABR at the EVL-YSL boundary in Tg(actb2:mNeonGreen-zo-1b) and 
Tg(actb2:mNeonGreen-zo-1bΔABR) transgenic MZzo-1b/3 mutant embryos at 7-8 hpf. Scale bar, 20 
µm. 
(D’) Kymograph of flow velocities of ZO-1b and ZO-1b-ΔABR along the animal-vegetal (AV) axis of 
the embryo as a function of time during epiboly in exemplary embryos at 7-8 hpf. Kymograph ranges 
from negative values (in blue), indicating retrograde flows towards the EVL margin, to positive values 
(in red), indicating anterograde flows towards the vegetal pole. 
(D’’) Plot of mean flow velocities along AV axis averaged over 10-30 min for the conditions described 
in (D) between 7 and 8 hpf. ZO-1b with N=3, n=4 embryos, ZO-1b-ΔABR with N=3, n=8 embryos. 
(E,E’) Plot of non-junctional fluorescence intensity of full-length ZO-1b (E) and ZO-1b-ΔABR (E’) as a 
function of distance from the EVL margin in MZzo-1b/3 mutant embryos injected with GFP-zo-1b (50 
pg) and GFP-zo-1b-ΔABR (44 pg) mRNA in Ctrl conditions or after injection of 0.3-0.5 pg caRhoA 
mRNA into the YSL. Data are mean ± s.e.m. Mann-Whitney test for ZO-1b with *p=0.0175, not 
significant for ZO-1b-ΔABR. Full-length ZO-1b: Ctrl with N=6, n=7 embryos and caRhoA mRNA YSL-
injected with N=4, n=7 embryos. ZO-1b-ΔABR: Ctrl with N=3, n=5 embryos and caRhoA mRNA YSL-
injected with N=4, n=7 embryos.  
 
Figure S6. Characterization of mechano-insensitive ZO-1b constructs and localization of TJ 
proteins. Related to Figure 6. 
(A) Sum intensity projections (SUM) of GFP-ZO-1b and GFP-ZO-1bΔC localization in MZzo-1b/3 
mutant embryos at the EVL-YSL boundary at 8 hpf. Scale bar 20 µm. 
(A’) Total intensity measurement normalized to laser power for the conditions described in (A). Data 
are shown as box-and-whisker plots (Whiskers: Tukey). Mann Whitney test; ns, not significant. ZO-1b 
with N=2, n=20 embryos; ZO-1bΔC with N=2, n=21 embryos. 
(B) Sketch of how junctional integration efficiency (Jie) was calculated: number of clusters merging 
and integrating with the EVL-YSL junction (Ji) subtracted by the number of clusters dissociating from 
the junction (Jd) and leaving towards the internal or external YSL.  
(B’) Bar plot of junctional ZO-1b cluster integration efficiency in MZzo-1b/3 mutant embryos injected 
with either GFP-zo-1b (50 pg) mRNA or GFP-zo-1bΔABR mRNA (44 pg) normalized to a 3 min time 
window.  
(C) Snapshots of 3D tracking of ZO-1b and ZO-1bΔABR non-junctional clusters in MZzo-1b/3 mutant 
embryos injected with either GFP-zo-1b (50 pg) mRNA or GFP-zo-1bΔABR mRNA (44 pg) at the first 
and last time points at 7-8 hpf. The EVL movement was corrected in order to keep the EVL-YSL 
junction fixed in y at position 0 (see Materials and Methods). Scale bar, 2 µm.  
(C’) Single plane of yz of ZO-1b and ZO-1bΔABR cluster tracking with clusters typically being 
incorporated into the TJ for ZO-1b, and flowing below the TJ into the internal YSL or detaching from 
the junctional pool for ZO-1bΔABR (indicated by white arrow heads). White dashed line indicates 
apical side of YSL facing the outside. Scale bar, 1 µm (1st and 3rd row) and 2 µm (2nd row). 
(C’’) Tracks of non-junctional clusters for the conditions described in (C). Region shaded in grey 
outlines the EVL-YSL junction in yz direction; region shaded in pink outlines the internal YSL 
positioned animally from the EVL-YSL junction, where usually almost no cluster detachment is 
observed for ZO-1b, while for ZO-1bΔABR a substantial fraction (7%) of clusters detach (pink region); 
region shaded in lilac shows clusters positioned further away from apical YSL surface, where many 
more ZO-1bΔABR than ZO-1b clusters were found (82% vs. 11%).  ZO-1b with N=2, n=3 embryos; 
ZO-1bΔABR with N=3, n=3 embryos. 
(D) MIPs of F-Actin (Phalloidin) of YSL-Ctrl (phenol red injected), zo-1b/3 YSL-morphant (1.5 ng, 0.5 
ng MO into the YSL) and zo-1b/3 YSL-morphant embryos co-injected with GFP-tagged zo-1bΔC (15 
pg) and zo-3 (5 pg, mutated for MO recognition site) as well as GFP-tagged zo-1bΔABR (22 pg) and 
zo-3 (mutated) mRNAs at 8 hpf. Scale bar, 10 µm. 
(D’) Plot of F-Actin intensity as a function of distance from EVL margin for the conditions described in 
(D). YSL-Ctrl with N=2, n=6 embryos, zo-1b/3 YSL-morphant with N=2, n=4 embryos, zo-1b/3 YSL-
morphant embryos co-injected with a combination of zo-3 (5 pg, mutated for MO recognition site) and 
either GFP-tagged zo-1bΔC mRNA (15pg) with N=2, n=6 embryos or GFP-tagged zo-1bΔABR  
mRNA (22 pg) with N=2, n=6 embryos. Statistical testing with Mann-Whitney test. Ctrl vs. zo-1b/3 
YSL-morphant with **p = 0.0095, Ctrl or zo-1b/3 YSL-morphant vs. zo-1b/3 YSL-morphant plus zo-
3/zo-1bΔC mRNA with *p = 0.0152 and ns, respectively;  Ctrl or zo-1b/3 YSL-morphant vs. zo-1b/3 
YSL-morphant plus zo-3/zo-1bΔABR mRNA  with **p = 0.0022 and ns, respectively. ns, not 
significant. 
(E) MIPs of GFP-tagged Claudin-D (30 pg) and mcherry-tagged ZO-1b (70 pg) localization at the 
EVL-YSL boundary at 8 hpf. Scale bar, 2µm. 
(F) MIPs of mNEON-tagged Occludin-A (30-50 pg) and mcherry-tagged ZO-1b (70 pg) localization at 
the EVL-YSL boundary at 8 hpf. Scale bar, 2µm. 
(G) MIPs of GFP-tagged ZO-1b (50 pg) and mcherry-tagged Cingulin-like 1 (50 pg) co-localization at 
the EVL-YSL boundary at 8 hpf. Scale bar, 2µm. 
(G’) Colocalization analysis (Pearson’s R value) of GFP-tagged ZO-1b and mcherry-tagged Cingulin-
like 1 in wild type (wt) embryos at 8 hpf. Pearson’s R value = 0.8, indicating strong colocalization 
between the two proteins. N=3, n=9 embryos.  
LEAD CONTACT AND MATERIALS AVAILABILITY  
 
Further information and requests for resources, reagents, data, and code should be addressed to the 
Lead Contact, Carl-Philipp Heisenberg (heisenberg@ist.ac.at). 
 
EXPERIMENTAL MODEL AND SUBJECT DETAILS 
 
Zebrafish (Danio rerio) maintenance and embryo collection were carried out as described 
(Westerfield 2007). Embryos were raised at 25-31oC in E3 medium or Danieaus’ buffer and staged as 
described (C. B. Kimmel et al. 1995). Embryos from TL or AB strains were used as wild type control 
embryos. Fish were bred in the zebrafish facility at IST Austria according to local regulations, and all 




CRISPR/Cas9 mutant generation 
For target site determination of CRISPR/Cas9 mutants of zo-1b (also known as tjp-1b, ZFIN ID: ZDB-
GENE-070925-1) and zo-3 (also known as tjp-3, ZFIN ID: ZDB-GENE-030828-10) genes, the 
CHOPCHOP tool was used (http://chopchop.cbu.uib.no/index.php) (Labun et al. 2016; Montague et 
al. 2014). The following target sites were chosen:  targeting exon number 13 (3rd PDZ domain) in zo-
1b and ‘g(A)GCAAATGGGGACGCGGCAGTGG’ targeting exon number 3 (1st PDZ domain) in zo-3. To 
increase the mutagenesis efficiency, the first (A) in the zo-3 target site was mutated to a g (Gagnon 
et al. 2014). To generate gRNA, a cloning-free method described in (Talbot and Amacher 2014) was 
used. Briefly, sgDNA templates were generated via PCR with the following general oligos: gRNA 
Primer 1: 5’ - GCGTAATACGACTCACTATAG - 3’, gRNA primer 2: 5’ - AAAGCACCGACTCGGTGCCAC - 3’ 
and  sgDNA_rv: 5‘ - 
AAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTTAACTTGCTATTTCTAGCTCT
AAAAC - 3’ and gene specific oligos: zo-1b oligo: 5‘ - 
GCGTAATACGACTCACTATAGTGGGCTTGAGGCTCGCTGGGTTTTAGAGCTAGAAATAGCAAG - 3’ and zo-3 
oligo: 5‘ - GCGTAATACGACTCACTATAgGCAAATGGGGACGCGGCAGGTTTTAGAGCTAGAAATAGCAAG - 
3’. Ambion  MAXIscript T7 kit was used to transcribe sgRNA in vitro. sgRNA was co-injected with cas9 
mRNA (transcribed from Addgene plasmid pCS2-Cas9 #47322 (Gagnon et al. 2014)) and a STOP 
cassette (GTCATGGCGTTTAAACCTTAATTAAGCTGTTGTAG flanked by 20nt homology arms). To 
determine indel frequencies, genomic DNA was prepared via HotSHOT protocol (Meeker et al. 2007) 
and the following primer pairs were used for identification of positive insertions of the STOP 
cassette: PCR of entire locus of zo-1b (5’ - TGA AGG TGT TGA GAG AGA GCA G - 3’ and 5’ - 
CGTTTTTAGGACGTCTCTCACC - 3’), zo-3 (5’ - TTC TGT CTT TCA CAG GAT TCC A - 3’ and 5’ - CAT AAC 
AAT CTG ATC TCG CGT C - 3’); PCR of STOP cassette insertion site (5’ - 
CATGGCGTTTAAACCTTAATTAAGCTGTTG - 3’ in combination with gene-specific reverse primer; gene-
specific forward primer in combination with 5’ - CAACAGCTTAATTAAGGTTTAAACGCCATG - 3’). 
 
Finally, the following mutations in zo-1b and zo-3 mutants were identified: 
zo-1b mutant (#14):          462 aa before STOP codon (*)  
…APVPSVTHDDSILRPSMKLVKFKKGESVGLRHDV* 
zo-3 mutant (#13):           44 aa before STOP codon (*)       
MEEMTIWEQHTVTLSKDSKVGFGFAVSGGLDKPNPANGDAGHGV* 
 
Frequently, we observed smaller egg sizes in the case of MZzo-1b single mutants and sometimes also 
in the MZzo-1b/3 double mutants. For quantification of EVL epiboly movement in those mutants, we 
thus only used wild type eggs with similar sizes as controls. 
 
While we were able to rescue the zo-1b/3 morphant phenotype by co-injection of  zo-1b and zo-3 
mRNA, attempts to rescue the MZzo-1b/3 mutant phenotype by zo-1b and zo-3 mRNA injection 
frequently resulted in gain-of-function phenotypes, reflected by ectopic constriction of the yolk cell 
by the circumferential actomyosin ring within the YSL. This difference in the efficiency of rescuing 
the morphant compared to the mutant phenotype might be due to difficulties in achieving the right 
level of expression in the mutant but not the morphant required for a successful rescue. This could 
be due to the upregulation of other zo genes in mutants (Figure S2H) but not morphants as a result 
of potential nonsense-mediated decay (El-Brolosy et al. 2019). 
 
Cloning of expression constructs 
Wild type TL or Tuebingen embryos were collected at 4 hpf or 8 hpf, dechorionated and total RNA 
was extracted from 10-15 embryos per sample using Trizol (Invitrogen). cDNA library was generated 
with the Superscript III reverse transcription kit according to manufacturer’s instructions. Coding 
region of zebrafish ZO-1b (splice variant: ENSDART00000112588.5), ZO-3 (splice variant: 
ENSDART00000012336.10) and Cingulin-like 1 (splice variant: ENSDART00000129769.4) were cloned 
with following primers: zo-1b (5’ - GGGG ACA AGT TTG TAC AAA AAA GCA GGC TTC ATG TCT GCC 
CGG GCT GC - 3’ and 5’ - GGG GAC CAC TTT GTA CAA GAA AGC TGG GTC TCA GAA GTG GTC GAT CAG 
CAC - 3’), zo-3 (5’ - GGGG ACA AGT TTG TAC AAA AAA GCA GGC TTC ATG GAG GAG ATG ACG ATA 
TGG G - 3’ and 5’ - GGG GAC CAC TTT GTA CAA GAA AGC TGG GTC TTA CAG CTC TGT AGC AGG TCC - 
3’) and cingulin- 
like 1 (5’ - GGGG ACA AGT TTG TAC AAA AAA GCA GGC TTA ATG GAG TCG TAC AGA GT TGG T - 3’ and 
5’ - GGG GAC CAC TTT GTA CAA GAA AGC TGG GTA TCA CAT TGA GAA ACT GGA GAT - 3’). 
Occludin-A was cloned from 5604348 (IMAGE ID) cDNA clone ordered from Source BioScience with 
following primers: oclnA (5’ - GGGG ACA AGT TTG TAC AAA AAA GCA GGC TTC ATG TCG TCG AAG CAC 
ATC GG - 3’ and 5’ - GGG GAC CAC TTT GTA CAA GAA AGC TGG GTC GGA TCT GCG GTC GTA ATC GC - 
3’). 
PCR products were used to generate entry vectors via recombining with pDONR(P1-P2) 
(Lawson#208) and the entry clone was further recombined with pCS-N-term-EGFP (Lawson #223) or 
pCS-N-term-mCherry (Lawson #362) destination vector (zo-1b, zo-3, cingulin-like1) or p3E 
mNEONgreen, pCS2-Dest (Lawson #444) for C-terminal tagging (occludin-A).  
 
For morphant rescue experiments, a slightly shorter transcript of zo-1b was expressed (splice 
variant: ENSDART00000112588.5) that is not targeted by the MO. For zo-3 morphant rescue, four 
mutations were introduced into the MO recognition site of zo-3 (pCS2-GFP-zo-3_4mismatch): 5‘ - 
GAa GAG ATG ACc ATt TGG GAa CAG CAC ACG -3’.  
 
To obtain the different zo-1b deletion constructs, the following primers were used to generate 
different truncated constructs: GFP-ZO-1b-ΔC (5’ - TGA GAC CCA GCT TTC TTG TAC AAA G - 3’ and 5’ - 
AAT GAC TGG CGG GTC CTC TCG C - 3’), GFP-ZO-1b-ΔABR (5’ - AGC GCT GGA GTA AAC CGC TTC - 
3’ and 5’ - AGG TTT GGG GTG CCG CGG - 3’).  
 
The desired truncations were amplified with PCR, followed by DpnI digest to remove template DNA 
(methylated DNA). T4 Polynucleotide kinase kit (NEB) was used for 5’ phosphorylation of DNA for 
subsequent ligation with T4 ligase kit (NEB). Transformation was performed in One Shot™ TOP10 
Chemically Competent E. coli (Thermo Fisher Scientific). 
 
Transgenic zebrafish line generation 
The Tol2/Gateway technology was used to generate transgenic fish lines (Kwan, Fujimoto, and 
Grabher 2007; Villefranc, Amigo, and Lawson 2007). For ZO-1b, ZO-1b-ΔABR flow imaging and FRAPs, 
lines ubiquitously expressing mNEONgreen-tagged ZO-1b and ZO-1bΔABR were generated. The 
following primers with gateway arms were used to amplify the coding region of zo-1b 
(ENSDART00000112588.5) from a cDNA library of wild type TL embryos at 8 hpf or from zo-1b-ΔABR 
template plasmid: 
5‘ - GGGGACAGCTTTCTTGTACAAAGTGGCTATGTCTGCCCGGGCTGCCTCTAAT - 3’  
5’ - GGGGACAACTTTGTATAATAAAGTTGCTCAGAAGTGGTCGATCAGCACAGAC - 3’.  
PCR products were used to generate entry vectors via recombing with pDONRP2r-P3 (Lawson#211) 
and entry clones were further recombined with pDestTol2pA2 (Chien #394), p5E-β-actin promoter 
(Chien#229), pME mNeonGreen (Shaner et al. 2013) (mNeonGreen licensed by Allelebiotech) and 
p3E-polyA (Chien#302). Transposase mRNA (Invitrogen) along with the Tol2 construct were co-
injected into wild type embryos (TL strain) to generate Tg(actb2:mNEONgreen-zo-1b) transgenic line. 
To generate the transgenic lines MZzo-1b/3;Tg(actb2:mNeonGreen-zo-1b) and MZzo-1b/3; 
Tg(actb2:mNeonGreen-zo-1bΔABR), the respective constructs were co-injected with transposase 
mRNA into MZzo-1b/3 mutant embryos.  
 
Tg(actb1:myl12.1-mcherry;actb2:mNEONgreen-zo-1b) and Tg(actb2:mNeonGreen-zo-1b; 
actb1:Utrophin-mcherry) transgenic lines were generated by crossing Tg(actb2:mNEONgreen-zo-1b) 
with pre-existing Tg(actb1:myl12.1-mcherry) or Tg(actb1:Utrophin-mcherry) lines, respectively.  
Other transgenic lines used were Tg(actb1:myl12.1-eGFP) and Tg(actb1:myl12.1-mcherry) (Maître et 
al. 2012; Behrndt et al. 2012) to follow cortical flow rates and perform laser cuts, and Tg(actb2:Lyn-
TdTomato) (Compagnon et al. 2014) to label cell membranes for tracking EVL margin progression. 
 
mRNA and Morpholino injections 
mRNA transcription was performed using the SP6 mMessage mMachine Kit (Ambion). Glass 
capillaries (30-0020, Harvard Apparatus) were pulled using a needle puller (P-97, Sutter Instruments) 
and mounted on a microinjection system (PV820, World Precision Instruments). Injections at one-
cell stage were performed as described (Westerfield 2007). YSL injections were performed at high 
stage (3.3 hpf). 0.2% Phenol red was co-injected as control. For caRhoA overexpression experiments, 
we locally increased actomyosin contraction within the YSL by injecting a single marginal blastomere 
at 128-cell stage, because global YSL expression of caRhoA resulted in premature constriction of the 
actomyosin band, and consequently in embryo lysis. The following mRNAs were injected: 
membrane-RFP (Iioka, Ueno, and Kinoshita 2004), membrane-GFP (R. A. Kimmel and Meyer 2010), 
lifeact-RFP (Behrndt et al. 2012) to label cell membranes and cortical actin for tracking EVL margin 
progression, H2A-mCherry (Arboleda-Estudillo et al. 2010) and H2B-GFP (Keller et al. 2008) to mark 
the YSL injection sites by locally labelling nuclei. Concentration of mRNAs are specified in the 
individual figure legends. 
 
The following Morpholino (MO) sequences were used to generate translation initiation MO: zo-1b 
(ENSDART00000173656.2 - longest variant): 5’ - GTCCGCCAAAGACAGACAAGAGCAT -3’; zo-3 
(ENSDART00000012336.10 - longest variant, ENSDART00000147070.3, ENSDART00000139911.2): 5’ 
- GCTCCCATATCGTCATCTCCTCCAT - 3’. Titration curves with different zo-1b/3 MO concentrations 
and different amounts of zo-1b/3 mRNAs were performed to find a dose of MOs, which induces 
phenotypes that can be rescued. This dose (1.5 ng zo-1b MO and 0.5 ng zo-3 MO) was then injected 
into MZzo-1b/3 mutants at one-cell stage to exclude that additional (potentially unspecific) 
phenotypes are induced. As further controls, 5-base mismatch control MOs (zo-1b 5-base mismatch 
MO 5’ - GTgCGgCAAAGAgAcACAAcAGCAT - 3; zo-3 5-base mismatch MO 5’ -  
GgTCgCATATCcTCATCTCgTCgAT - 3’) and a standard negative control MO (human beta-globin MO 5’ 
- ‘CCTCTTACCTCAGTTACAATTTATA’ - 3’, Gene Tools) were used. 
 
Sample preparation for live imaging 
Embryos were dechorionated and mounted in 0.3-0.5% low melting point (LMP) agarose (Invitrogen) 
for live imaging on glass bottom dishes (MatTek). Fixed samples were mounted in 0.5-1% LMP 
agarose and put into prepared agarose moulds (2%) for upright imaging. Live embryos were imaged 
at 28.5oC ± 1oC. 
 
Imaging setups for live and fixed imaging 
For live imaging, Leica SP5 inverted microscope equipped with a 20x/0.7 CS objective. (HC PL APO, 
11506513 WD=0.59 mm, D=0.17 mm) was used. For imaging fixed samples, Leica SP5 inverted 
microscope equipped with a 40x objective (HCX PL APO 40x/1.25-0.75 OIL CS - 11506251, WD=0.1 
mm, D=0.17 mm) or Leica SP5 upright equipped with a 25x/0.95 W dipping lense (HCX IRAPO L, 
11506323, WD=2.5 mm) were used.  
 
Analysis of EVL progression 
To determine EVL progression throughout development, the height of EVL (hEVL ) was normalized to 
the total embryo height (hTOT ), and then normalized to the average time needed by control embryos 
and plotted as a function of time. In general, the interval time was set by the acquisition time (10 
min); in case of different acquisition times, the EVL progression was interpolated to gain intervals of 
10 min. Data of Figure 6D-D’,E-E’ were randomized before quantification of total EVL epiboly 
duration.  
 
Whole mount in situ hybridization 
Embryos at 10.5 hpf were fixed in 4% PFA and then dehydrated and stored for at least 1 day at -20oC. 
Following rehydration in 1xPBS, in situ hybridization was performed as previously described 
(Montero et al. 2005). Antisense RNA probe for papc was synthesized from partial cDNA sequence 
via mMESSAGE mMACHINE™ T7 Transcription Kit (ThermoFisher AM1344) and DIG-RNA labeling 
mix (Sigma, 11 277 073 910). A stereomicroscope (Olympus SZX 12) equipped with QImaging 
Micropublisher 5.0 camera was used to take images of whole mount embryos. 
 
UV laser ablation 
Inverted Zeiss microscope (Axio Observer Z1) equipped with a 355 nm UV-A laser and a 63x/1.2 W 
objective (Korr UV-VIS-IR, 421787-9970) was used to assess junctional tension (Behrndt et al. 2012). 
Junctional cuts were performed on Tg(actb1:myl12.1-eGFP) (Maître et al. 2012) embryos by cutting 
at 10 equidistant sites along a 5 µm line perpendicular to the junction with 25 UV pulses at 1 kHz. 
Time for junctional laser ablation was 300-350 msec and for subsequent imaging 300 msec. For 
determining recoil velocities, first the movement of the junction was corrected (via stackreg function 
in ImageJ), and  a line was drawn along the junction, including the position of ablation to generate a 
kymograph. The kymograph was then used to extract the opening distance after junctional ablation. 
A linear fit was performed on the first 4 post-cut distances when plotting distance (in µm) versus 
time (in s) (see Fig S2I-I’,J-J’). Cases where a wound response after UV cutting was detected were 
excluded from the quantification. 
 
Imaging of cortical flows within the YSL 
For imaging cortical flows of Myosin-2, Tg(actb1:myl12.1-eGFP) (Maître et al. 2012) embryos were 
used, and for simultaneously monitoring ZO-1b and Myosin-2 flows, Tg(actb1:myl12.1-mcherry; 
actb2:mNEONgreen-zo-1b) embryos were used. High-resolution confocal imaging was performed on 
a spinning disk setup (Axio Observer Z1, Zeiss) equipped with 100x/1.4 Oil/DIC (Plan APOCHROMAT, 
420792-9900). Z-stacks of 5-10 µm (0.5 µm in z) were acquired by recording multiple positions along 
the animal-vegetal (AV) axis of the YSL within the same embryo at a maximum acquisition time of 15 
sec. Afterwards, the different positions were stitched via ImageJ plugin (Preibisch, Saalfeld, and 
Tomancak 2009). Particle image velocimetry (PIV) analysis on maximum intensity projections was 
performed by using PIVlab in matlab after applying a CLAHE filter (Contrast Limited Adaptive 
Histogram Equalization) to enhance the local contrast of the images. In order to gain mean flow 
profiles along the AV axis, the linear EVL movement was corrected in order to keep the EVL margin 
fixed at position 0. From these plots, the peak EVL and YSL flow velocities were extracted to 
determine whether flow rates had changed in the different conditions. Movies lasted for 5-30 min.  
 
ZO-1b cluster size and circularity analysis 
For high spatiotemporal resolution imaging of non-junctional ZO-1b clusters within the YSL, an Axio 
Observer Z1 inverted microscope (Zeiss, LSM880) equipped with Plan-Apochromat 63x / NA 1.4 Oil 
was used. For determining the average cluster area, a maximum intensity projection (MIP) was 
performed and the movement of the junction was corrected (via stackreg function in ImageJ). 
Images were further processed using Ilastik (Sommer et al. 2011) to train the program for properly 
detecting signal intensities versus background signal. After cluster segmentation, the average cluster 
area size over time was determined. Circularity was determined via using the plugin ‘Circularity’ in 
Fiji, which calculates circularity as 
 
Circularity = 4𝜋 ∗  
𝑎𝑟𝑒𝑎
𝑝𝑒𝑟𝑖𝑚𝑒𝑡𝑒𝑟2
.       Equation (1) 
 
A circularity value of 1 reflects a perfect circle, while values close to 0 indicate more elongated 
shapes. 
 
ZO-1b cluster fusion analysis 
For analyzing the cluster fusion rate, the FiJi plugin TrackMate, and specifically the ‘FindMaxima’ 
detector, was used to identify and track bright clusters on MIP images. From the tracking 
information, the cluster fusion events per time point were then extracted using a custom-made 
Python script.  
 
Quantitative imaging of ZO-1b 
Axio Observer Z1 inverted microscope (Zeiss, LSM880) equipped with Plan-Apochromat 63x / NA 1.4 
Oil in Airy Scan mode was used for obtaining GFP calibration curves to determine ZO-1b 
concentrations. Before each experiment, the Argon laser power was measured with a power meter 
to normalize to potential fluctuations. For obtaining GFP calibration curves, Matek dishes were 
coated in 1% BSA for 2h at RT and washed several times before addition of a GFP solution with 
known concentration. GFP protein solutions were diluted in 1xPBS. Three images per GFP dilution 
were acquired and averaged. Finally, fluorescence intensity of GFP protein dilutions were plotted 
against protein concentration (Figure S5A) and the resulting equation of the linear relationship was 
used to convert fluorescence intensity to ZO-1b protein concentration in µM. 
 
ZO-1b junctional integration efficiency  
Non-junctional clusters of ZO-1b were manually tracked in maximum intensity projection images 
(MIP) using FIJI after EVL-YSL junctional movement correction (via stackreg function in ImageJ). The 
junctional integration efficiency was calculated as described in Figure S6B.  
 
Tracking analysis of non-junctional clusters 
For 3D tracking of non-junctional clusters of ZO-1b and ZO-1bΔABR (Figure S6C-C’’), the EVL 
movement was corrected in order to keep the EVL margin fixed at position 0 via the plugin ’correct 
3D drift’ in FIJI. Then, Imaris tracking ‘spots’ tool was used. Tracks in yz planes were extracted and a 
custom-made Matlab script was used to plot single tracks in yz axes. The percentages of tracks that 
bypassed the junction in z (lilac box) and tracks that detached from the junction (pink box) were 
calculated and indicated within the boxes.  
 
Immunostaining 
Immunostaining was performed as  described (Köppen et al. 2006). Briefly, embryos were fixed in 4% 
paraformaldehyde overnight at 4 °C. For ZO-1 and ZO-3 immunohistochemistry, fixed embryos were 
washed in 0.1% Triton X-100 (in PBS) and dechorionated. After another washing step embryos were 
permeabilized in 0.5% Triton X-100 for 1h and blocking was performed in blocking solution (10% 
normal goat serum, 1% DMSO, 0.3% Triton in PBS) for 3-5h at room temperature (RT). Embryos were 
incubated with primary antibodies in blocking solution overnight at 4 °C. Primary antibodies used 
were mouse anti-ZO-1 (Invitrogen) at 1:50, and rabbit anti-ZO-3 (Benais-Pont et al. 2003) (gift from 
Karl Matter) at 1:300. After washing the embryos in 0.1% Triton in PBS, they were incubated for 3-4h 
in secondary antibody solutions at RT or at 4 °C overnight and washed again before imaging. 
 
For E-Cadherin, α- and β-Catenin staining, embryos were dehydrated after fixation and stored in 
100% Methanol at -20 °C overnight. After rehydration, embryos were washed in PBS and incubated 
in 0.5% Triton X-100 for 1h and blocking was performed in blocking solution (0.5% Tween-20, 0.5% 
Triton X-100, 1% DMSO, 1% BSA in PBS) for 3-5 h at RT. Embryos were incubated with primary 
antibodies (rabbit anti - zebrafish E-Cadherin, 1:200, generated at MPI-CBG; rabbit α-Catenin 1:1000, 
Sigma; mouse anti-β-Catenin, 1:500, Sigma) in blocking solution at 4 °C overnight. Embryos were 
washed 4x 20 min in blocking buffer and then incubated with secondary antibodies in blocking 
solution for 3-5 h at RT. Secondary antibodies used were goat anti-mouse/rabbit conjugated to Alexa 
Fluor 488/594/647 (Molecular probes). To label F-Actin, Phalloidin conjugated to Alexa Fluor 
488/Rhodamine/647 was added to the secondary antibody solutions. Finally, embryos were washed 
4x 20 min in 0.5% Tween in PBS. 
 
Junctional and YSL cortical quantifications 
For quantification of junctional intensities of immunostained embryos, z-stack planes were summed 
via SUM projection (in ImageJ), and of GFP-tagged and mNEONgreen-tagged protein expression 
constructs (Cingulin-like 1, Claudin-D, Occludin-A, ZO-1b, ZO-1b-ΔC and ZO-1b-ΔABR), maximum 
intensity projection was performed. A 1 µm segmented line was then drawn along EVL-YSL and EVL-
EVL junctions to measure mean fluorescence intensity. For cytoplasmic signal intensities a window of 
around 5x5 µm was analyzed. For quantification of non-junctional intensities of YSL cortical signals, a 
mask of the YSL region was generated and average intensity values along the distance to the EVL 
were extracted after background subtraction.  
 
Quantification of total intensities 
GFP-tagged constructs were injected into MZzo-1b/3 embryos and z-stack planes were summed via 
SUM projection (in ImageJ) over a 10 µm thickness. A 70 µm x 70 µm window was selected and total 
intensity was normalized to the used laser power. 
 
qRT-PCR (quantitative Real-Time PCR) 
Wild type TL and MZzo-1b/3 embryos were collected at 6 hpf, dechorionated and total RNA was 
extracted from 10-15 embryos per sample using Trizol (Invitrogen). To ensure complete removal of 
any contaminating genomic DNA, DNA-free™ DNA Removal Kit (Thermo Fisher Scientific) was used. 
cDNA library was generated with the Superscript III reverse transcription kit according to 
manufacturer’s instructions. Equal amounts of mRNA were used from different samples for the 
actual qRT-PCR experiment. Experiments were repeated 3 times independently in triplicates. 
Absolute QPCR SYBR Green Mixes (Thermo Scientific) and Bio-Rad C1000 Thermal Cycler was used 
for qRT-PCR reaction. As negative control, cDNA library generation was performed without adding 
the reverse transcriptase. As positive control and for later normalization, the housekeeping gene 
elongation factor 1α (Miesfeld et al. 2015) was used. To determine the linear range, different 
concentrations of cDNA concentrations were tested to finally use a 1:10 cDNA dilution. Primers were 
used at a final concentration of 105 nM: zo-1b (5’ - CAACAACATCAACGCCATTC - 3’ and 5’ - 
CCACAACTGTGTGTCCCTCA - 3’), zo-3 (5’ - ACCTGGAGGAACCCTTAGGA - 3’ and 5’ - 
TGTAGGGAGGTTCAGGGCTA - 3’), zo-1a (5’ - CCAGCTACAACCGTTTTGTG - 3’ and 5’ - 
TTGGGAGTCATTAGGGAGGA - 3’), zo-2a (5’ - CATCATACCCAGCAAGAGCA - 3’ and 5’ - 
CTCCAGAAATCGCCTCTGTC - 3’) and zo-2b (5’ - GATTACCGCAGCCAGGACTA - 3’ and 5’ - 
GTCCCTCCGGTACCCACT - 3’).  
 
Colocalization analysis 
Images for colocalization analysis of ZO-1b and Myosin-2 were acquired on a Zeiss LSM880 inverted 
microscope (Airyscan mode, Plan-Apochromat 63x / NA 1.4 Oil) using Tg(actb1:myl12.1-mcherry; 
actb2:mNEONgreen-zo-1b) embryos at 6-8 hpf and colocalization of cingulin-like 1 and ZO-1b 
images were acquired by injecting mcherry and GFP-tagged versions into wild type embryos at 8 hpf. 
After determining the point spread function and the chromatic shift between channels (via imaging 
TetraSpeck Microspheres with the size of 100 nm), the mcherry channel was corrected for chromatic 
shift using DoM ‘Detection of Molecules’ plugin in ImageJ, and images were analyzed by using 
‘Coloc2’ plugin in ImageJ. As a quantitative measure for colocalization analysis of ZO-1b and Myosin-
2, Li’s Intensity Correlation Quotient (Li’s ICQ) was determined, best suited for the rather complex 
and heterogeneous distribution of channel intensities in our samples (also see scatter-plot in Figure 
S5B’) (Q. Li et al. 2004; Bolte and Cordelières 2006). Li’s ICQ value ranges from 0.5 showing 
colocalization to -0.5 showing exclusion with values close to 0 indicate random localization. As a 
quantitative measure for colocalization between Cingulin-like 1 and ZO-1b, Pearson’s R value was 
determined by using ‘Coloc2’ plugin in ImageJ, which was best suited for the observed linear 
relationship between the two protein species (also see scatter-plot in Figure S6G’) (Bolte and 
Cordelières 2006). 
 
Fluorescence Recovery After Photobleaching  
 
Data acquisition 
Fluorescence Recovery After Photobleaching (FRAP) experiments were performed on a Spinning Disk 
System (Andor, iXon 897, backthinned EMCCD) assembled on an Axio Observer Z1 microscope (Zeiss) 
equipped with a 40x/1.2 W objective (C-APOCHROMAT, Korr UV-VIS-IR). Three pre-bleach frames 
were acquired for estimating the level of bleaching followed by bleaching a 5x5 µm window with a 
488 nm laser. For bleaching, a dwell time of 20-60µs and 5-30x repeats at laser powers of 9-15% was 
used. Several junctions within the field of view were bleached, but only one junction per cell. Due to 
the continuous movement of the EVL-YSL junction, a 10µm z-stack was imaged with an acquisition 
time of 10 sec. 
 
Data analysis 
For FRAP analysis at the EVL-YSL boundary, sum intensity projection was performed on z-stacks of 
the EVL-YSL junction. The ImageJ plugin ‘stackreg with rigid body transformation’ was used to 
correct for movement of the junction and to keep the FRAP window at a constant position. Then, a 1 
µm thick line was drawn along the junction and the signal along the thickness of the line was 
averaged via the ‘KymoResliceWide’ function. Finally, a 5 µm thick line was used to measure the 
intensities before and after bleaching on the generated kymograph (see white dashed box in Figure 
S4A-A’,B-B’).  
 
Background (BG) subtraction was performed by measuring signal outside of the junctional region of 
the pre-bleach frame (IBG) to obtain the background corrected intensity at the EVL-YSL junction (IJ-
BGcorr) and at the reference EVL-EVL junctions (IRef-BGcorr). 
 
IJ -BGcorr(t) = IJ(t) - IBG        Equation (2) 
 
IRef -BGcorr(t) = IRef(t) - IBG        Equation (3) 
 
Next, to obtain the intensity corrected for bleaching (IJ-BLcorr), the intensity of junctional signal was 
divided by a reference signal (average of two EVL-EVL junctions): 
 
IJ-BLcorr(t) = IJ -BGcorr(t) / IRef -BGcorr(t)      Equation (4) 
 
The bleach corrected intensity was then normalized to the mean pre-bleach intensity (average of 
three pre-bleach frames, N=3):  
 
IJ-norm (t) = 1
𝑁
∑  𝑁  IJ-BLcorr(t)       Equation (5) 
 
For the analysis of non-junctional FRAPs, initial data analysis was carried out as described for 
junctional FRAPs. A 5 µm thick line was drawn along the non-junctional pool and the signal along the 
thickness of the line was averaged via the ‘KymoResliceWide’ function. Finally, a 5µm thick line was 
used to measure the intensities before and after bleaching on the generated kymograph (see white 
dashed box in Figure 4E-E’,F-F’). Background subtraction was carried out as described for junctional 
FRAPs - Equation (2,3). Then, the background corrected intensities of the non-junctional signal (InJ -
BGcorr(t)) and the reference signal (IRef -BGcorr(t)) were normalized to three pre-bleach frames. 
 
InJ-norm (t) = 1
𝑁
∑  𝑁  InJ -BGcorr(t)       Equation (6) 
 
IRef-norm (t) =  1
𝑁
∑  𝑁 IRef -BGcorr(t)       Equation (7) 
 
Finally, the change in signal of the reference region (unbleached non-junctional region) was 
deducted from the non-junctional intensity measurements to account for retrograde flow that 
would otherwise also contribute to signal recovery within the bleached window: 
 
InJ-norm;corr (t) = InJ-norm (t) - [ IRef-norm (t) - 1]     Equation (8) 
 
Latrunculin B treatment 
Dechorionated embryos were mounted in 0.5% low melting point agarose containing 1 ug/ml 
Latrunculin B or DMSO as control at the onset of epiboly (4.3 hpf). Danieau’s medium containing 
1ug/ml Latrunculin B (EMD Millipore) or DMSO (Sigma) was then added. After a 1h incubation 
period, embryos were imaged with Axio Observer Z1 inverted microscope (Zeiss, LSM880) equipped 
with Plan-Apochromat 63x / NA 1.4 Oil in Airy Scan mode at 5.3 till 6.3 hpf. 
 
QUANTIFICATION AND STATISTICAL ANALYSES 
Graphpad Prism 6 was used for statistical analysis. All data were tested for normal distribution with 
‘D'Agostino & Pearson omnibus normality test’. In case data passed normality test (alpha=0.05), then 
a parametric test, such as unpaired t test or ordinary one-way ANOVA (in the case of multiple 
comparisons) was used. In case the data did not pass the normality test, a non-parametric test was 
used (Mann-Whitney test or Kruskal-Wallis test for multiple comparisons). To correct for multiple 
comparisons either Tukey’s multiple comparisons test (for ordinary one-way ANOVA) or Dunn’s 
multiple comarisons test (for Kruskal-Wallis test) was used. The individual statistical tests used for 
experiments are mentioned in the according figure legends. In general, N were considered as 
independent experiments and n were determined either as number of embryos or number of cells, 
which is specified in the individual figure legends.  
 
DATA AND CODE AVAILABILITY 
All data and code supporting the current study are available from the corresponding author upon 
request.   
Supplemental Videos: 
 
Video S1: zo-1b/3 function is specifically required within the YSL to ensure proper EVL 
epiboly.  Related to Figure 2. 
Time-lapse brightfield/fluorescence movie of embryos labeled with membrane RFP to detect EVL and 
deep cells of exemplary embryos for control YSL-injected, zo-1b/3 MO YSL-injected, and zo-1b/3 MO 
together with GFP-tagged zo-1b and zo-3 mRNA YSL-injected conditions. EVL-YSL boundary is 
marked by white dashed line to demarcate extent of EVL epiboly in the different conditions.Time-
interval: 10 min. Time: 4-11 hpf. Scale bar: 100 µm.  
 
Video S2: zo-1b/3 regulate actomyosin flow rates within the YSL. Related to Figure 2. 
Time-lapse movie of maximum intensity projections (MIPs) of myosin-2 flow during epiboly in an 
exemplary YSL-Ctrl (left panel), zo-1b/3 YSL-morphant embryo (middle panel) and zo-1b/3 YSL-
morphant embryo rescued with GFP-zo-1b/3 mRNA (right panel) at 7-8 hpf. Fluorescent signal of 
myosin-2 (left side) was overlaid with vectors (in green - right side) obtained by PIV analysis to 
indicate the flow velocities along the animal-vegetal (AV) axis of the embryo. Time-interval: 15 sec. 
Scale bar: 10 µm. 
 
Video S3: Non-junctional ZO-1b flows with similar velocity as cortical actomyosin. Related to 
Figure 4. 
Time-lapse movie of maximum intensity projections (MIPs) of myosin-2 (left panel) and ZO-1b (right 
panel) flow in Tg(actb1:myl12.1-mcherry; actb1:mNEONgreen-zo-1b) embryos at 7-8 hpf. 
Fluorescence signal of myosin-2 and ZO-1b (left side) were overlaid with vectors (in green - right side) 
obtained by PIV analysis to indicate the flow velocities along the animal-vegetal (AV) axis of the 
embryo. Time-interval: 15 sec time. Scale bar: 10 µm.  
 
Video S4: Non-junctional ZO-1b clusters fuse within YSL. Related to Figure 4.  
Time-lapse movie of maximum intensity projections (MIPs) of high-resolution (Airy Scan) images of 
non-junctional ZO-1b clusters undergoing fusion close to the EVL-YSL boundary in a 
Tg(actb1:mNEONgreen-zo-1b) embryo at 6.5-8 hpf. To keep the non-junctional pool at a constant 
position, correction for EVL-YSL movement was performed.  Time-interval: 20 sec. Scale bar: 1 µm. 
 
Video S5: Fusion of non-junctional ZO-1b clusters occurs independently of actomyosin 
network contraction. Related to Figure 5. 
Time-lapse movie of maximum intensity projections (MIPs) of  high-resolution (Airy Scan) images of 
non-junctional ZO-1b clusters undergoing fusion in Tg(actb1:mNEONgreen-zo-1b) embryos treated 
for 1h with DMSO (left panel) or 1 µg/ml Latrunculin B (Lat B, right panel) prior to imaging at 5.3-6.3 
hpf. To keep the non-junctional pool at a constant position, correction for EVL-YSL movement was 
performed. Red arrowheads mark fusing ZO-1b droplets (right panel). Time-interval: 15 sec. Scale 
bar, 2 µm. 
 
Video S6: ZO-1b-ΔABR clusters show decreased junctional integration efficiency. Related to 
Figure 6.  
Time-lapse movie of maximum intensity projections (MIPs) of ZO-1b (left panel) and ZO-1b-ΔABR 
(right panel) non-junctional pool in MZzo-1b/3 mutant embryos injected with either GFP-zo-1b (50pg) 
or GFP-zo-1bΔABR (44pg) mRNA at 7-8 hpf. To keep the junction at a constant position, correction 
for EVL-YSL movement was performed. Black arrowheads point at clusters of ZO-1b that get 
successfully incorporated into the EVL-YSL junction (left panel), while non-junctional clusters of ZO-
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KEY RESOURCES TABLE 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 




Anti-ZO-3 rabbit Antibody Benais-Pont et al. 
2003 N/A 
Anti-E-Cadherin (zebrafish) rabbit Antibody Maître et al. 2012 N/A 
Anti-alpha-Catenin antibody produced in rabbit Sigma-Aldrich Cat# C2081, 
RRID:AB_476830 
Monoclonal Anti-beta-Catenin antibody produced in 
mouse 
Sigma-Aldrich Cat# C7207, 
RRID:AB_476865 
























Bacterial and Virus Strains  
Biological Samples   
Chemicals, Peptides, and Recombinant Proteins 
GFP protein Gift from Alf 
Honigmann (MPI CBG 
Dresden) 
N/A 
Latrunculin B EMD Millipore Cat# 428020-1MG 
 
DMSO Sigma Cat# D8418-100ML; 
CAS: 67-68-5 
Critical Commercial Assays 
Deposited Data 
Experimental Models: Cell Lines 
Experimental Models: Organisms/Strains 
Zebrafish: TL wild-type  N/A 
Zebrafish: AB wild-type  N/A 
Zebrafish: Tuebingen wild-type  N/A 
Zebrafish: MZzo-1b this study N/A 
Zebrafish: MZzo-3 this study N/A 
Zebrafish: MZzo-1b/3 this study N/A 
Zebrafish: Tg(actb2:mNeonGreen-zo-1b) this study N/A 
Zebrafish: MZzo-1b/3; Tg(actb2:mNeonGreen-zo-1b) this study N/A 
Zebrafish: MZzo-1b/3; Tg(actb2:mNeonGreen-zo-
1bΔABR) 
this study N/A 
Zebrafish: Tg(actb1:Utr-mCherry) Behrndt et al. 2012 N/A 
Key Resource Table
 
Zebrafish: Tg(actb1:myl12.1-GFP) Behrndt et al. 2012; 




Zebrafish: Tg(actb1:myl12.1-mcherry) Behrndt et al. 2012; 





this study N/A 
Zebrafish: Tg(actb2:mNeonGreen-zo-1b; 
actb1:Utrophin-mcherry) 
this study N/A 







pCS2-GFP-zo-1b (zebrafish version) This study N/A 
pCS2-mcherry-zo-1b (zebrafish version) This study N/A 
pCS2-GFP-zo-3 (zebrafish version) This study N/A 
pCS2-GFP-zo-3_4mismatch (zebrafish version) This study N/A 
pCS2-mcherry-zo-3 (zebrafish version) This study N/A 
pCS2-mcherry-cingulin-like 1 (zebrafish version) This study N/A 
pCS2-Occludin-A-mNEONgreen (zebrafish version) This study N/A 
pCS2-GFP-Claudin D (zebrafish version) Gift from Ashley Bruce 
(University of Toronto) 
N/A 
pCS2-GFP-zo-1b-ΔC (zebrafish version) This study N/A 
pCS2-GFP-zo-1b-ΔABR (zebrafish version) This study N/A 
pTol2-actb2:mNEONgreen-zo-1b (zebrafish version) This study N/A 
pTol2-actb2:mNeonGreen-zo-1bΔABR (zebrafish 
version) 
This study N/A 
pCS2-membrane-RFP 
 





R. A. Kimmel and 
Meyer 2010 
N/A 
pCS2-lifeact-RFP Behrndt et al. 2012 N/A 
pCS2-H2A-mCherry Arboleda-Estudillo et 
al. 2010 
N/A 
pCS2-H2B-GFP Keller et al. 2008 N/A 
Software and Algorithms 





GraphPad Prism GraphPad Software https://www.graphpa
d.com/scientific- 
software/prism/ 








Ilastik Sommer et al. 2011 https://www.ilastik.or
g/ 
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PDZ PDZ PDZ SH3 GUK ABR U5 U6ZO-1b full length ZU5 
Actin binding region (ABR) 
U5 U6PDZ PDZ PDZ SH3 GUKZO-1b ΔC






































































































































< 0.5 µM ZO-1b ~ 1 µM ZO-1b > 4 µM ZO-1b
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